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Sammenfatning 
Baggrund 
Der er en stigende bekymring for, at selv lave eksponeringer for pesticider 
under udviklingen af reproduktionsorganer og nervesystem, kan medføre 
vedvarende skader på disse organsystemer. Fostre (og hermed gravide 
kvinder) og børn antages derfor at være særlige sårbare grupper i forhold til 
pesticideksponering. 
 
Det overordnede formål med dette projekt var at undersøge effekter af tre 
hyppigt anvendte triazolfungicider, tebuconazol, propiconazol og 
epoxiconazol, på det endokrine system med speciel fokus på køns- og 
skjoldbruskkirtelhormoner. Desuden ønskede vi at sammenligne resultaterne 
med vores tidligere fund for imidazolfungicidet prochloraz, som viste sig at 
have hormonforstyrrende egenskaber i en række in vitro og in vivo 
undersøgelser. Hvis de tre triazolforbindelser har tilsvarende effekter som 
prochloraz tyder det på at disse effekter er generelle for azolfungicider. 
 
Azol-fungicider anvendes i store mængder til bekæmpelse af 
svampesygdomme i kornafgrøder og i mindre omfang i prydplante-, 
grøntsags- og frugtproduktionen. I 2005 blev der således i Danmark samlet 
anvendt over 100 t aktivstof af disse midler. Da de er relativt fedtopløselige og 
let optages over mave-tarmkanalen kan befolkningen blive udsat for stofferne, 
hvis de findes som rester i fødevarerne. Aktuelt kontrolleres restindholdet af 
stofferne i frugt og grønt, men kun få azol-fungicider måles i korn og 
kornprodukter. Bl.a. måles det mest anvendte azol-fungicid, epoxiconazol, 
ikke, hvorfor det ikke er muligt at foretage en samlet vurdering af 
befolkningens eksponering gennem kosten. Generelt har azol-fungiciderne en 
lav akut giftighed, men der vides meget lidt om deres mulige sundhedsrisici 
ved lave kroniske eksponeringer. Vi har for nylig vist at azol-fungicidet, 
prochloraz, kan interagere med flere forskellige receptorer, heriblandt 
østrogenreceptoren (ER), androgenreceptoren (AR) og arylhydrocarbon 
receptoren (AhR) i cellebaserede in vitro assays. Desuden virkede prochloraz 
anti-androgent i voksne hanrotter og påvirkede serumkoncentrationerne af 
skjoldbruskkirtelhormoner. Ved eksponering i drægtighedsperioden og under 
diegivningen medførte stoffet en virilisering af hun-ungerne og en 
feminisering af han-ungerne. 
 
AhR er en nuklear transkriptionsfaktor, som efter binding af ligand, medfører 
øget genekspression af AhR responsive gener så som CYP1-genfamilien. Den 
klassiske AhR ligand er 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) men 
også andre planare aromatiske polycycliske molekyler kan aktivere receptoren. 
Der er endnu ikke identificeret en naturlig endogen ligand. AhR medieret 
induktion af CYP1A1 og 1A2 vil blandt andet føre til øget omdannelse af 
østradiol til 2- og 4-hydroxyøstradiol og kan derfor påvirke organismens 
hormonkoncentration. 
 
I dette projekt har vi undersøgt om de tre mest anvendte triazol-forbindelser i 
Danmark: epoxiconazol, propiconazol og tebuconazol, besidder de samme 
egenskaber som imidazolfungicidet prochloraz med hensyn til at reagere med 
ER, AR og AhR og til at påvirke steroidhormonsyntesen og aktiviteten af 
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enzymet aromatase, som konverterer testosteron til østrogen. Effekterne er 
undersøgt i etablerede in vitro assays. Desuden har vi etableret et bioassay (T-
screen) til at undersøge binding til og aktivering af receptoren for 
skjoldbruskkirtlens hormoner, thyroxin (T4) og tri-iodothyronin (T3), og 
anvendt dette assay til at undersøge om prochloraz, epoxiconazol, 
propiconazol og tebuconazol kan virke som T3/T4 agonister eller 
antagonister. 
 
Dernæst har vi undersøgt anti-androgene virkninger for tebuconazol og 
propiconazol in vivo i unge voksne hanrotter i Hersberger testen. Endelig er 
effekter på fostres udvikling undersøgt for epoxiconazol og tebuconazol ved at 
dosere hunrotter i drægtigheds- og diegivningsperioden og undersøge fostre 
og unger. 
 
Årsagen til at propiconazol blev erstattet med epoxiconazol i undersøgelserne 
vedrørende effekter på fostrets udvikling, er at vi efter projektets start fik 
oplysninger om at forbruget af epoxiconazol var steget markant i 2004 og nu 
var det mest anvendte azolfungicid i dansk landbrug. 
 
In vitro effekter 
De tre azolfungicider, propiconazol, tebuconazol og epoxiconazol kunne alle, i 
lighed med prochloraz, virke hormonforstyrrende via flere forskellige 
mekanismer, selvom deres potens i nogle assays var lavere end for prochloraz. 
 
De tre triazoler var således mindre potente ER antagonister (prochloraz > 
tebuconazole ≈ epoxiconazole ≈ propiconazole) og AhR agonister (prochloraz 
>>> tebuconazole ≈ epoxiconazole ≈ propiconazole) end prochloraz mens 
deres affinitet for AR svarede til prochloraz. Ligesom prochloraz hæmmede 
triazolerne enzymet aromatase dog igen med mindre potens end prochloraz 
(prochloraz >epoxiconazole ≈ tebuconazole > propiconazole). 
 
Evnen til at påvirke syntesen af steroidhormoner blev undersøgt i en human 
binyrebark-cancercelle H295R. I lighed med prochloraz øgede alle tre 
triazolfungicider produktionen af progesteron mens produktionen af 
testosteron og østrogen var reduceret. Dette indikerer en hæmning af enzymer 
som er involveret i omdannelsen af progesteron til testosteron. 
 
Ingen overbevisende effekter blev observeret med hensyn til interaktion med 
receptoren for skjoldbruskkirtlens hormoner for hverken prochloraz eller nogle 
af triazolerne. 
 
Anti-androgene virkninger in vivo 
I Hershberger testen, hvor anti-androgene effekter undersøges in vivo, havde 
hverken propiconazol eller tebuconazol i doserne 50, 100 eller 150 mg/kg 
lgv/dag nogen effekt på vægten af reproduktionsorganer eller på 
hormonniveauer, undtagen for den højeste dosis af propiconazol, hvor der var 
en signifikant stigning i serumkoncentrationen af follikel stimulerende hormon 
(FSH). Den eneste signifikante effekt på genekspressionen var nedsat 
ekspression af ornithin decarboxylase (ODC) mRNA i ventrale prostata ved 
alle doser af propiconazol og ved den højeste dosis af tebuconazol. Dette gen 
reguleres af androgener, men også via andre mekanismer. Da der ikke sås 
andre anti-androgene effekter (nedsat vægt af androgenafhængige organer, 
nedsat ekspression af andre androgenregulerede gener eller en stigning i LH) 
er det sandsynligt, at den observerede effekt på ODC mRNA skyldes en 
mekanisme som ikke er reguleret af androgener. 
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Konklusionen er derfor, at ingen af de to triazol-fungicider, propiconazol eller 
tebuconazol, blokerer androgen receptoren in vivo i Hershberger testen ved 
doser på 150 mg/kg lgv/dag og derunder. Dette er i kontrast til prochloraz, 
som inducerede markante anti-androgene effekter i Hersberger assayet ved 
doser mellem 50 og 150 mg/kg lgv/dag. 
 
Effekter på afkommet efter perinatal eksponering 
Drægtige rotter blev doseret med epoxiconazol (15 eller 50 mg/kg lgv/dag) 
eller tebuconazol (50 eller 100 mg/kg lgv/dag). Nogle dyr fik udført planlagt 
kejsersnit på gestationsdag (GD) 21 for at undersøge effekter på fostrene. 
Andre dyr fødte normalt og afkommet blev undersøgt enten ved fødslen eller 
postnatal dag (PND) 13 eller 16 efter at havde været yderligere eksponeret 
gennem modermælken. Den højeste dosis af epoxiconazol medførte øget 
fosterdød og gav tydelige problemer med de almindelige fødsler. Derfor blev 
der kun født 2 kuld mens de resterende moderdyr i denne gruppe fik foretaget 
kejsersnit mellem GD23 og GD25 og blev inkluderet i gruppen som fik 
foretaget kejsersnit ved GD21. Tolkningen af resultaterne fra undersøgelser af 
unger fra højdosis epoxiconazol gruppen er derfor vanskelige og der kan ikke 
drages endelige konklusioner. 
 
De nedenstående effekter blev observeret for moderdyr, fostre og afkom: 
Både epoxiconazol og tebuconazol øgede drægtighedslængden. Det har vi 
også tidligere set for prochloraz (30 mg/kg lgv/dag). Denne effekt skyldes 
sandsynligvis, at azol-fungiciderne inducerer et øget progesteron niveau hos 
mødrene. 
 
Afstanden mellem anus og kønsorganerne (’anogenital distance’, AGD) var 
øget i hununger efter dosering af mødrene med den højeste dosis af 
tebuconazole, samt den laveste dosis af epoxiconazol. Dette indikerer en 
virilisering af hunungerne. For de samme to dosisgrupper var der ingen effekt 
på AGD i nyfødte hanunger. Efter dosering med den højeste dosis 
tebuconazol var testosteronkoncentrationen i hanfostrenes testikler nedsat, 
mens progesteron og 17α-hydroxyprogesteron var øget ved begge doser af 
tebuconazol. Tebuconazole medførte yderligere en signifikant stigning i 
antallet af brystvorter samt en tendens til nedsat plasmakoncentration af 
testosteron i hanungerne. Det overordnede billede er således at tebuconazol 
viriliserer hunungerne og feminiserer hanungerne i lighed med prochloraz. 
 
Epoxiconazol har tilsyneladende en vækstfremmende effekt på hanungerne. 
En højere fødselsvægt af ungerne er sandsynligvis forårsaget af et markant 
forøget testosteronniveau i moderdyret, der kan tænkes at virke 
vækstfremmende på ungerne. Dette kan også forklare den umiddelbare 
tendens til øget AGD i hanfostre og støttes af en ikke signifikant tendens til 
øget vægt i androgen-afhængige organer i hanunger.  Alt i alt tyder 
resultaterne på at epoxiconazol’ virkningsprofil på hanunger er forskellig fra 
prochloraz’ og tebuconazols’ virkningsmåde. Stoffet er markant 
fosterbeskadende og hvilke mekanismer der ligger til grund for denne effekt og 
om hormonforstyrrelser er en del af årsagen, kan ikke siges ud fra vores 
forsøg. 
 
Konklusion 
Overordnet viser resultaterne fra dette projekt, at azol-fungicider generelt har 
samme virkningsprofil in vitro, men at virkningsprofilen in vivo er forskellig 
fra stof til stof. Resultaterne fra in vitro forsøgene viser at alle fire azoler har 
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potentialet til at virke hormonforstyrrende via en række forskellige 
mekanismer. Potensen af de tre triazoler som indgår i denne undersøgelse: 
epoxiconazol, propiconazol og tebuconazol var enten lig med eller lavere end 
imidazolfungicidet prochloraz’ i de anvendte in vitro assays. Propiconazol og 
tebuconazol udviste ingen AR blokerende virkning in vivo i Hershberger 
assayet. Til trods for dette var både epoxiconazol og tebuconazol i stand til at 
medføre effekter på udviklingen af det reproduktive system i afkommet efter 
eksponering i livmoderen. Både epoxiconazol og tebuconazol inducerede 
virilisering af hunafkommet, mens tebuconazol også medførte feminisering af 
hanafkommet. Derudover virkede epoxiconazol generelt fosterbeskadende. 
Samlet set har de tre undersøgte azolfungicider haft det til fælles at de alle 
øger drægtighedslængden, de viriliserer hunungerne og de forøger 
progesteronniveauerne. 
 
Disse effekter kan skyldes at flere virkningsmekanismer, som virker på samme 
tid, forstærker det samlede biologiske respons. Effekterne på 
steroidhormonsyntesen in vitro, udeblivelse af effekter i Hershberger assayet 
(hvor effekter på hormonsyntesen omgås ved at anvende kastrerede, 
testosteron supplementerede handyr) kombineret med effekterne på 
udviklingen af det reproduktive system efter perinatal eksponering tyder 
kraftigt på at en af hovedmekanismerne er forstyrrelse af nøgle-enzymer i 
steroidhormonsyntese. 
 
De observerede virkninger fortjener videre undersøgelser med henblik på at 
afdække ved hvilke doser effekterne opstår og for at opnå flere oplysninger om 
hvilke mekanismer, der er involveret. Resultaterne fra projektet har givet ny 
viden om azol-fungiciders toksiske virkningsmekanismer og mulige 
sundhedsmæssige effekter på reproduktionen og det endokrine system og vil 
derfor kunne bidrage til en bedre risikovurdering for denne meget udbredte 
gruppe af svampemidler. 
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Summary  
Background 
There is a growing concern of permanent damage to the endocrine and 
nervous systems after exposure to even low levels of pesticides under 
development. Fetuses (i.e., pregnant women) and children are therefore 
considered as particularly vulnerable groups in relation to pesticide exposure. 
 
The main objective of this project was to investigate the effects of three 
frequently used triazole fungicides, tebuconazole, propiconazole, and 
epoxiconazole on the endocrine system with special focus on sex and thyroid 
hormones. In addition, we wanted to compare the results with our previous 
findings for the imidazole fungicide, prochloraz, which was shown to possess 
endocrine disrupting effects in a number of in vitro and in vivo studies. If the 
triazole compounds possess similar effects as prochloraz these effects are 
likely to be general for the group of azole fungicides. 
 
Azole fungicides are used in large amounts for control of fungi in grain 
production and to a lesser extent in the flower, vegetable and fruit production. 
Thus, in 2005 a total amount of 100 t of azole fungicides was used in 
Denmark. The fungicides are relatively fat-soluble and readily absorbed in the 
gastrointestinal tract. Therefore, the public is exposed to the fungicides when 
residues exist in food products. Residues of azole fungicides are monitored in 
vegetable and fruit, but only few azole fungicides are monitored in grain and 
grain products. For instance, the most widely used azole, epoxiconazole, is not 
monitored, making it impossible to do a complete dietary exposure assessment 
of the Danish population. In general, the azole fungicides have a low acute 
toxicity but the knowledge about their potential health risks at low chronic 
exposures is very limited. We have recently shown that the azole fungicide, 
prochloraz, can interact with several receptors, including the estrogen receptor 
(ER), androgen receptors (AR), and the aryl hydrocarbon receptor (AhR), in 
cell-based in vitro assays. Besides, prochloraz was anti-androgenic in adult 
male rats and affected the serum concentration of thyroid hormones. After 
exposure during pregnancy and lactation it caused feminization of male and 
virilization of female offspring. 
 
The AhR is a nuclear transcription factor that, after binding of ligand, causes 
increased gene transcription of AhR responsive genes such as the CYP1 gene 
family. The classical AhR ligand is 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) but also other planar aromatic polycyclic molecules activates the 
receptor. No natural endogenous ligand has yet been identified. AhR 
mediated induction of CYP1A1 and 1A2 will enhance the metabolism of 
estradiol to 2- and 4-hydroxy estradiol (Rifkind, 2006) and could therefore 
affect the hormone concentration in the organism. 
 
In this project we have investigated whether the three actually most widely 
used triazole fungicides in Denmark: epoxiconazole, propiconazole, and 
tebuconazole, possess similar properties as the imidazole fungicide prochloraz 
regarding interactions with the ER, AR, and AhR, as well as effects on steroid 
hormone synthesis and the activity of the enzyme aromatase that converts 
testosterone to estrogen. The effects were investigated by established in vitro 
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assays. Furthermore, we have established a bioassay (T-screen) for detecting 
binding and activation of the thyroid receptor (TR) and used the assay to 
investigate the ability of prochloraz, epoxiconazole, propiconazole, and 
tebuconazole to be thyroid hormone agonists or antagonists. Additionally, we 
have investigated anti-androgenic effects of propiconazole and tebuconazole 
in vivo in young adult rats using the Hershberger assay. Finally, 
developmental effects of epoxiconazole and tebuconazole were investigated in 
rat offspring after exposure during pregnancy and lactation. 
 
The reason why propiconazole was replaced by epoxiconazole in the 
developmental study was that we, after the project was initiated, were 
informed that the use of epoxiconazole had increased markedly during 2004 
and now was the most widely used azole fungicide within Danish agricultural 
production. 
 
In vitro effects 
The three azole fungicides: propiconazole, tebuconazole, and epoxiconazole 
all had the potential, like prochloraz, to act as endocrine disruptors via several 
different mechanisms although the potencies were less than for prochloraz in 
some of the assays. 
 
Hence, the three triazoles were less potent than prochloraz to act as ER 
antagonists (prochloraz > tebuconazole ≈ epoxiconazole ≈ propiconazole) and 
AhR agonists (prochloraz >>> tebuconazole ≈ epoxiconazole ≈ 
propiconazole) while the potency as AR antagonists was similar. Like 
prochloraz, the triazoles were aromatase inhibitors, although again, with lower 
potency than prochloraz (prochloraz >epoxiconazole ≈ tebuconazole > 
propiconazole). 
 
The ability to interfere with steroid hormone biosynthesis was investigated in 
the human adrenocortical carcinoma cell line H295R. Like prochloraz, all 
three triazole fungicides caused enhanced production of progesterone and 
reduced production of testosterone and estradiol. This indicates that enzymes 
involved in the conversion of progesterone to testosterone are inhibited. 
 
Convincing interactions with the TR were not found for either prochloraz or 
any of the triazole fungicides. 
 
Anti-androgenic effects in vivo 
In the Hershberger assay, used for investigating anti-androgenic effects in 
vivo, propiconazole and tebuconazole (50, 100, or 150 mg/kg bw/day) had no 
effect on neither reproductive organ weights or on hormone levels, except for 
the highest dose of propiconazole, for which there was a significant increase in 
the serum concentration of follicle stimulating hormone (FSH). The only 
significant effect of the azole fungicides on gene expression was a decrease in 
of expression of ornithine decarboxylase (ODC) mRNA in prostate at all 
doses of propiconazole and at the highest dose of tebuconazole. This gene is 
regulated by androgens but is also regulated via other pathways. Since none of 
the other anti-androgenic end points (weight of androgen dependent organs, 
expression of other androgen responsive genes or serum concentration of LH) 
were affected we believe that the effects observed on ODC mRNA expression 
are due to a non-androgen-regulated pathway. 
 
In conclusion, none of the triazole fungicides, propiconazole or tebuconazole, 
had any androgen receptor blocking effect in vivo in the Hershberger test at 
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doses at or below 150 mg/kg bw/day. This is in contrast to prochloraz that 
induced anti-androgenic effects in this assay at doses between 50 and 150 
mg/kg bw/day. 
 
Effects on offspring after perinatal exposure 
Pregnant rats were dosed with epoxiconazole (15 or 50 mg/kg bw/day) or 
tebuconazole (50 or 100 mg/kg bw/day). Some dams were chosen for 
caesarian section at gestational day 21 (GD21) to evaluate effects on sexual 
differentiation in the fetuses. Other dams delivered normally and the pups 
were examined at birth or at post natal day (PND) 13 or 16 after exposure 
during lactation. The highest dose of epoxiconazole caused marked fetal 
lethality and problems with normal delivery. Therefore only two litters were 
born normally and the remaining dams in this group had caesarian sections 
between GD23 and GD25 and they were included in the group having 
caesarian sections at GD 21. Interpretation of the results from examination of 
the offspring from the high dose epoxiconazole group is therefore hampered 
and no final conclusions can be drawn. 
 
The following effects were observed for dams, fetuses, and offspring: 
Both epoxiconazole and tebuconazole caused an increased gestational length 
as we have also previously seen for prochloraz (30 mg/kg bw/day). This effect 
is probably caused by a marked increase in plasma concentrations of 
progesterone in the mothers induced by both fungicides. 
 
The anogenital distance (AGD) was increased in the female pups in the 
highest tebuconazole dose group and the lowest epoxiconazole dose group 
indicating a virilizing effect on the females. No effect on AGD was seen in the 
newborn male pups. The testosterone level in testis from the male fetuses was 
decreased by tebuconazole, while progesterone and 17α-hydroxyprogesterone 
levels were increased at both doses. Furthermore, tebuconazole caused a 
significant increase in the number of nipples in the male pups and a tendency 
towards decreased plasma testosterone concentration in male pups. Thus, the 
overall picture is that tebuconazole virilizes the females and feminizes the male 
pups. 
 
Epoxiconazole had an apparent growth-promoting effect on the male 
offspring. A higher birth weight was seen which is probably caused by the 
enhanced testosterone level in the epoxiconazole-dosed mothers. The 
testosterone may have acted as a growth promoter and may have caused the 
increased AGD in the fetuses and the insignificant tendency towards an 
increased weight of androgen dependent reproductive organs in male pups. In 
summary, the results indicate that the profile of effects induced by 
epoxiconazol on male offspring is different from the effects induced by 
prochloraz and tebuconazol. Epoxiconazol has marked fetotoxic effects but 
the mechanisms behind and the potential role of endocrine disruption for 
these effects cannot be ruled out from this study. 
 
Conclusion 
Overall the results from this study indicate that azole fungicides in general 
have a similar profile of action in vitro but that the profile of action in vivo is 
different and varies from chemical to chemical. The four azole fungicides all 
have the potential to act via several modes of actions. The potencies of the 
three triazoles included in this study, epoxiconazole, propiconazole, and 
tebuconazole, were similar or less than for the imidazole fungicide, 
prochloraz, in the applied in vitro assays. Propiconazole and tebuconazole did 
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not possess androgen receptor blocking effect in vivo in the Hershberger test 
at doses at or below 150 mg/kg bw/day. Despite this, both epoxiconazole and 
tebuconazole were capable of inducing effects on reproductive development 
in the offspring after exposure in utero. Both epoxiconazole and tebuconazole 
virilized the female offspring, and tebuconazole also caused feminizing effects 
in male offspring. In addition epoxiconazol had marked fetotoxic properties. 
The common features for the tested azole fungicides are that they all increase 
gestational length, they virilize female pups, and they increase progesterone 
levels. 
 
These effects are likely due to several different mechanisms operating 
simultaneously and thereby enhancing the integrated biological response. 
However, the effects on steroid hormone synthesis in vitro, the lack of effect in 
the Hershberger assay (where effects on steroid synthesis is omitted by using 
testosterone supplemented castrated male rats) combined with the effects on 
reproductive developmental after perinatal exposure strongly indicate that one 
of the main responsible mechanisms is disturbance of key-enzymes involved 
in the synthesis of steroid hormones. 
The observed effects deserve further investigations in order to unveil the 
doses needed to induce the effects and to obtain more information on the 
mechanisms involved. The results from the project add new knowledge about 
the toxic mechanisms of azole fungicides and their potential for inducing 
health effects on reproduction and the endocrine system and will contribute to 
a better risk assessment of this widely used group of fungicides. 
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Abbreviations 
17β-HSD: 17β-Hydroxysteroid Dehydrogenase  
AGD:  Anogenital distance 
AhR:  Arylhydrocarbon receptor 
ALH:  Amplitude of lateral head displacement 
AR:   Androgen receptor 
ARE:  Androgen-responsive-element  
ATCH:  Adrenocorticotropic hormone 
CHO cells:  Chinese hamster ovary cells 
Compl. C3:   Complement component 3 
CYP:  Cytochrom P450 
DCC:  Dextran charcoal treated fetal calf serum 
DMSO:       Dimethyl sulfoxide 
DREs:  Dioxin Responsive Elements 
DTT:          1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane 
EPA:  Environmental Protection Agency 
ER:              Estrogen receptor 
FBS:             Fetal bovine serum 
FCS:            Fetal calf serum  
FSH:   Follicle stimulating hormone 
GD:             Gestational day 
GH3:  A rat pituitary tumor cell line 
H295R cells:  Human adrenocortical carcinoma cells 
H4II3 cells:  Rat hepatoma cells 
ICx:              Inhibitory concentration x % 
IFMA:  Immuno fluorometric assay 
IGF-1:          Insulin-like-growth factor 1 
LABC:  Levator ani/bulbocavernosus muscles 
LDH:           Lactate dehydrogenase 
LH:              Luteinizing hormone 
LOEC:          Lowest observed effect concentration 
LOEL:  Lowest observed effect level 
LUC:  Luciferase 
MCF-7 cells: a human breast cancer cell line 
MOEC:  Maximum observed effect concentration 
MMTV:  Mouse mammary tumor virus 
ODC:            Ornithin decarboxylase 
P450c17:  CYP17a1 
P450scc:  Cytochrom P450-side-chain cleavage 
PBP C3:        Prostate specific binding protein polypeptide C3 
PBR:  Peripheral benzodiarepine receptor 
PBS:  Phosphate buffered saline   
PCR:            Polymerase chain reaction 
PEM:  Placenta and Embryos oncofetal gene 
PND:            Postnatal day 
RPE:              Relative proliferative effect 
RT-PCR:      Reverse transcriptase PCR 
sc:               Subcutane 
ScarB1:  Scavenger receptor class B. member 1 
StAR:            Steroidogenic acute regulatory protein 
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STR:  Straightness 
T3:                Triiodothyronine 
T4:                Thyroxine 
TR:  Thyroid hormone receptor  
TRPM-2:      Testosterone-repressed prostate message 2 
TSH:            Thyroid stimulating hormone 
VAP:  Average path velocity 
VCL:  curvilinear velocity 
VSL:  Straight line velocity 
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1 Introduction  
1.1 Background 
Exposures to pesticides during early development may cause permanent 
damages to the nervous and reproduction systems (Nielsen et al., 2001). 
Therefore, children and fetuses (i.e. pregnant women) are particularly 
vulnerable towards pesticide exposure. This is due to the fact that the nervous 
and reproductive organ systems are not fully developed until late childhood 
and children have a higher dietary intake in relation to body weight than 
adults (Nielsen et al., 2001). Besides, children often consume relatively much 
fruit and juice, which can be polluted with pesticides. Very little is known 
about the potential health risks at low chronic exposures but even low 
concentrations of endocrine disrupting pesticides in the diet might be of 
concern due to potential combination effects (Birkhoj et al., 2004;Rajapakse et 
al., 2002;Silva et al., 2002). 
 
Pesticides approved in Denmark have to be tested for adverse effects on 
reproduction and offspring by OECD guidelines TG 414 (Pre-natal 
Developmental Toxicity Study), 415 (One Generation Reproduction 
Toxicity Study), 416 (Two Generation Reproduction Toxicity Study), and 
421 and 422 (Reproduction/Developmental Toxicity Screening Test) 
(http://www.oecd.org/home/). However, these test systems do not have an 
optimal design for revealing functional disruptions in the reproduction and 
nervous systems. 
 
Recently we tested a range of commonly used pesticides for the ability to 
disrupt the endocrine system using a battery of in vitro tests (Andersen et al., 
2002; Long et al., 2003). The pesticides were chosen due to their frequent use 
in Danish greenhouse horticultures (Andersen and Nielsen, 2001). Two 
thirds of the pesticides had endocrine disrupting properties and induced 
significant response in one or more of the in vitro tests. One of these pesticides 
was the imidazole fungicide prochloraz, which interacted in all the test 
systems. Prochloraz possessed anti-estrogenic and anti-androgenic effects, 
inhibited the activity of the estrogen synthesizing enzyme aromatase and 
activated the aryl hydrocarbon receptor (AhR). The AhR (or dioxin receptor) 
is an intracellular receptor that mediates the toxic responses of dioxin and 
related chemicals. Binding of a ligand to the receptor induce gene 
transcription of the CYP1A gene family and thereby the activity of some 
cytochrome P450 enzymes involved in the synthesis or metabolism of steroid 
hormones are increased (Rifkind, 2006). 
 
In later studies, we found that prochloraz also induced anti-androgenic effects 
in rats in vivo (Vinggaard et al., 2002) and feminized male offspring in rats 
after perinatal exposure (Vinggaard et al., 2005a). The effects observed for 
prochloraz were comparable to effects reported for the fungicide vinclozolin 
(Gray, Jr. et al., 1994;Gray, Jr. et al., 1999a), which was banned because of its 
anti-androgenic effects. Furthermore, prochloraz decreased the concentration 
of thyroxin (T4) and thyroid stimulating hormone (TSH) in serum of exposed 
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rats (Vinggaard et al., 2005a) indicating interference with the thyroid 
function. 
 
In Denmark the use of fungicides has been increasing with a total sale of 1625 
t in 2001, 1744 t in 2003, and 2046 t in 2005. (Miljøstyrelsen, 2004 
;Miljøstyrelsen, 2006). The azole fungicides are used in large amounts in the 
control of fungi in grain and to a lesser extent in flower, vegetable and fruit 
production. The total amount of azole fungicides (as active ingredients) sold 
in Denmark in 2005 was over 100 t. Epoxiconazole alone accounts for 47 t 
(approximately half of the azole fungicides used) and prochloraz, 
propiconazole, and tebuconazole, accounts for 2, 31, and 26 t, respectively 
(Miljøstyrelsen, 2006). 
 
The azole fungicides are relatively lipophilic and are absorbed through the 
gastrointestinal tract (Kampmann et al., 1999). Therefore, the population can 
be exposed to azole fungicides through residues in the food. Residues of some 
azole fungicides are measured in fruit and vegetables but only few azoles are 
monitored in grain and grain products and for instance the most widely used 
azole fungicide in Denmark, epoxiconazole, is neither monitored in fruit, 
vegetables, grain nor grain products (Christensen et al., 2006). Assessment of 
the total dietary exposure to azole fungicides of the human population is 
therefore hampered. Although the maximal residue limit was not exceeded for 
the individual azole compounds included in the 2005 survey, prochloraz or 
tebuconazol was detected in several samples of fruits and vegetables produced 
in Denmark or imported (Christensen et al., 2006). 
 
It is well known from the literature that several azole fungicides influence the 
activity of different cytochrome P450 enzymes and for instance inhibit the 
activity of aromatase (CYP19) which converts androgens to estrogens 
(Mason et al., 1987; Sanderson et al., 2002; Sanderson, 2006). Besides some 
in vitro studies on enzyme activities and our previous studies on prochloraz, 
only few other toxicological studies of these pesticides have been published 
despite of their massive use in agriculture and horticulture. In one study, 
exposure of pregnant rats to tebuconazole in doses around Lowest Observed 
Effect Level (LOEL) caused reduced weight of adult epididymis in male 
offspring and reduced adult uterus weight in female offspring. In addition, 
changes in behavior were observed (Moser et al., 2001). 
 
Prochloraz, propiconazole, and tebuconazole were assessed by the Danish 
Environmental Protection Agency (EPA) in 1998, 1996, and 1996, 
respectively (Pesticidkontoret, 1996a; Pesticidkontoret, 1996b; 
Pesticidkontoret, 1998). The toxicological assessments were mainly based on 
the studies reported by the manufactor in order to get the product approved 
by the authorities. At that time, none of the pesticides were assessed to be 
toxic to the reproduction system. Both prochloraz and tebuconazole were 
reported to disturb the thyroid function but this was not considered to be of 
importance to human health. Prochloraz was re-assessed in 2004 and based 
on new studies and a review of the endocrine disrupting effects of the 
compound from The Danish Institute for Food and Veterinary Research, 
prochloraz was categorized as toxic to the reproductive system and labeled 
with R61: “May cause harm to the unborn child” (Pesticidkontoret, 2004). 
Epoxiconazole was assessed in 2003 (Pesticidkontoret, 2003) and, classified 
as carcinogenic and toxic to the reproductive system in category 3 and labeled 
with R40, R62, and R63. 
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So far the research in endocrine disrupting mechanisms has primarily focused 
on disruption of sex hormones and related receptors but other mechanisms 
are also involved (Sharpe, 2006). Interference with steroid hormone 
biosynthesis (Sanderson, 2006) or the thyroid system (Boas et al., 2006) are 
other important pathways of endocrine disruption. 
 
The thyroid system is a central component of the endocrine system and 
thyroid hormones are essential for normal development and even small 
changes in thyroid homeostasis during critical periods of brain development 
may result in irreversible neurobiological damages and disruption of 
corresponding functions (Boas et al., 2006; Porterfield, 1994; Porterfield, 
2000). The fetus itself, do not produce thyroid hormone during the first half 
of the pregnancy and is consequently depending on the mothers hormones. 
Chemicals that can interfere with the thyroid hormone level of the mother are 
therefore suspected to be able to cause neurological damages to the child 
(Boas et al., 2006; Porterfield, 1994).  Ethylene thiourea, a metabolite of 
dithiocarbamate fungicides, is an example of a chemical that interferes with 
the thyroid system and causes thyroid hyperplasia and declined thyroid 
hormone levels (Lentza-Rizos, 1990). Different mechanisms of actions may 
be involved. The chemicals may bind directly to the thyroid hormone receptor 
(TR) or to the transport protein transthyretin or they may affect the release of 
TSH or the breakdown of thyroid hormones. For instance, the pesticides 
ioxynil, dicofol, and pentachlorphenol have been demonstrated to compete 
with triiodthyronine (T3) for the binding to transthyretin while they do not 
bind to the TR (Ishihara et al., 2003b; Ishihara et al., 2003a). 
 
Our research so far on prochloraz, combined with the few other studies of 
toxic effects of azole fungicides, indicate that these compounds have the 
potential to react through several mechanisms resulting in effects on various 
organ systems (Vinggaard et al., 2005a). Our concern was that the endocrine 
disrupting properties demonstrated for prochloraz also applied to other azole 
fungicides, including triazole and other imidazole compounds. Hence, the aim 
of this study was to investigate if three other commonly used azole fungicides: 
epoxiconazole, propiconazole, and tebuconazole, possess comparable effects 
to those observed for prochloraz regarding interactions with the ER, AR and 
AhR in vitro as well as anti-androgenic and developmental effects in vivo. In 
addition, we wanted to investigate if prochloraz and the three other azole 
compounds interact with the TR in vitro. 
 
Figure 1 illustrates the structure of the four azole fungicides. Prochloraz is an 
imidazole whereas the other three are triazoles. There is also a difference in 
the number of atomic chlorine attached to the phenyl rings and epoxiconazole 
differ from the others by containing atomic fluorine. 
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Figure 1 - Chemical structures of the four azole fungicides: epoxiconazole, 
prochloraz, propiconazole, and tebuconazole. 
 
1.2 Project Objectives 
The main objective of the project was to investigate the effects of three 
frequently used triazole fungicides on the endocrine system, including in vitro 
and in vivo examinations. Secondly, we wanted to compare the results with 
the imidazole fungicide, prochloraz, which previously has shown endocrine 
disrupting effects in a number of in vitro and in vivo studies. 
 
1.3 Hypothesis and Strategy 
The strategy of the project was to investigate: 
 
1. Whether the triazole fungicides epoxiconazole, propiconazole, and 
tebuconazole possess similar properties as the imidazole fungicide prochloraz 
regarding interactions with the ER, AR, AhR, as well as effects on steroid 
hormone synthesis and the activity of the enzyme aromatase that converts 
testosterone to estrogen. The effects are investigated by established in vitro 
assays and the results are compared to the effects previously obtained for 
prochloraz. Differences in effects between the triazoles and prochloraz may 
indicate that the nature of the azole ring and/or the placement of the halogens 
in the phenyl rings, have an impact on the biological effect (Figure 1). 
 
2. Whether prochloraz and the three triazoles interact with the TR. 
Tebuconazole and prochloraz have shown effects on the serum concentration 
of thyroid hormones in animal studies. The mechanism behind this effect is 
not known but one possibility is that the azole compounds may bind directly 
Epoxiconazole Prochloraz 
Propiconazole Tebuconazole 
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to the TR. Chemicals with the ability to react both with the ER, AR and AhR 
might be capable to also react with other receptors or binding sites as reported 
for several other environmental toxicants (Laws et al., 1995; Molina-Molina et 
al., 2006; Sanderson, 2006). We therefore wanted to investigate the molecular 
interaction of the four azole fungicides with the thyroid receptor. A T-screen 
assay was established for this purpose. 
 
3. Whether the three triazoles induce anti-androgenic effects in adult male rats 
(Hershberger assay). If so the effects will be compared with the effects 
previously obtained for prochloraz. Concentrations of pituitary and thyroid 
hormones and changes in expression of androgen responsive genes will be 
included to increase the sensitivity of the assay. Changes in gene expression, 
in the rat ventral prostate, are a valuable marker of anti-androgen action. 
Many genes contain an androgen-responsive-element (ARE) in the promoter 
region and their expression is directly influenced by the amount of androgens 
or anti-androgens available (Nellemann et al., 2005). 
 
4. Whether exposure to epoxiconazole or tebuconazole during pregnancy and 
lactation will cause effects on the offspring in rats. The fetus is the most 
sensitive stage of the organism towards endocrine disrupters. In an earlier 
study, feminization of male offspring was demonstrated after prochloraz 
exposure during pregnancy and lactation. The effects included feminization 
of male genitals, female-like areolas and feminized behavior. It is therefore 
highly relevant to investigate whether other azole fungicides induce similar 
endocrine disrupting effects during development. 
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2 Methods for testing endocrine 
disrupting effects of azole fungicides 
2.1 In vitro testing 
The first step in investigating endocrine disrupting properties of the azole 
fungicides was to screen the four compounds: epoxiconazole, prochloraz, 
propiconazole, and tebuconazole in a battery of cell assays for well-known 
mechanisms of endocrine disruption. The assay systems included the ability 
to induce proliferation in a human breast cancer cell line (MCF-7 cells) 
(estrogenic/anti-estrogenic effects), agonistic and antagonistic effects on the 
AR in transfected Chinese Hamster Ovary (CHO) cells, effects on activity of 
the estrogen synthesizing enzyme aromatase in the MCF-7 cell proliferation 
assay using testosterone as substrate, dioxin like effects estimated as activation 
of the Ah receptor in the CALUX assay, effects on thyroid function, by 
looking at the thyroid dependent cell proliferation of a rat pituitary tumour 
cell line (GH3 cells) in the T-Screen assay and finally effects on 
steroidogenesis in human adrenocortical carcinoma cells (H295R cells). 
 
2.1.1 Estrogen/anti-estrogen testing – MCF-7 cells 
The azole fungicides were tested for estrogenic and anti-estrogenic effects 
using a MCF-7 cell proliferation assay. The assay is based on a human breast 
cancer cell line. The cells depend on estrogen for growth. Proliferation of the 
cells is therefore an indication of the presence of an estrogen like compound. 
The method is used on a regular basis in many research laboratories including 
the laboratory at Environmental Medicine, University of Southern Denmark. 
The MCF-7 cell proliferation assay is considered to be the most reliable in 
vitro assay. It is of more humane physiologic relevance than other established 
in vitro assays as it is based on a mammal cell line which has not been 
manipulated genetically making the regulation of the estrogenic response 
more naturally (Andersen et al., 1999).  
In short, MCF-7 BUS cells were seeded in microtiter plates and after 24 h, 
dilutions (0.001-150 µM) of the azole fungicides were added for six days of 
incubation. The azole fungicides were tested with and without 10 pM 17β-
estradiol (which induces half of the maximum proliferation response in the 
cells) to detect both antagonistic and agonistic effects. Cells were fixed and 
stained. The number of living cells was measured using an ELISA-reader. 
Each experiment included a standard curve of 17β-estradiol ranging from 1 
pM to 10 nM and the maximum response was detected at 1 nM. The assay is 
very sensitive with a limit of detection of 0.5 pM 17β-estradiol and a 
quantification limit of 1 pM 17β-estradiol. Only results obtained with a 
standard curve slope within two times the standard deviation (estimated from 
a large number of independent experiments) was accepted. Furthermore, the 
mean control activity (based on minimum 3 wells) in each plate had to be 
within two times the standard deviation of controls to be included. This 
ensured a normal response from the cells and excluded increased background 
activity due to contamination. Each azole fungicide was tested in at least three 
independent experiments and in twenty-two different concentrations (0.001, 
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0.005, 0.01, 0.05, 0.1, 0.2, 0.39, 0.5, 0.78, 1, 1.56, 3.13, 5, 6.25, 10, 12.5, 30, 
50, 75, 100, 125, 150 µM) in triplets. Results are presented as the Relative 
Proliferative Effect (RPE) in which data are normalized both to untreated 
control cells and the maximum response induced by 1 nM 17β-estradiol in 
each experiment: 
RPE = [(PEtest sample-1)/(PEmax17β-estradiol-1)] x 100, where PE correspond to the 
response normalized in relation to control. The concentration-response 
relationships were plotted and fitted to the sigmoidal function: 
y=y0+a/[1+(x/x0)
b] 
 
2.1.2 Aromatase testing – MCF-7 cells 
The MCF-7 cells express the enzyme aromatase naturally. The enzyme 
converts testosterone to estrogen and hence induce proliferation of the cells 
(Sadekova et al., 1994;Sonne-Hansen and Lykkesfeldt, 2005). By co-treating 
the cells with testosterone and fungicides an inhibition or stimulation of the 
enzyme activity can be registered (Almstrup et al., 2002). Previously, the 
assay has been used (using 1 µM testosterone which induces about 65% of the 
maximum response of 17β-estradiol) for testing effects on aromatase activity 
by the fungicide fenarimol (Andersen et al., 2006). The results obtained were 
in good agreement with results obtained using other aromatase assays. 
Prochloraz has been demonstrated to inhibit aromatase activity in different in 
vitro assays (Andersen et al., 2002;Vinggaard et al., 2000). By including 
prochloraz in this study it is possible to confirm the sensitivity of this assay 
compared to other assays. Since the same assay system is used for 
investigating estrogenicity and effects on aromatase it is possible to compare 
directly the concentrations inducing these effects. 
Each azole fungicide was tested in three independent experiments at sixteen 
different concentrations (0.001, 0.005, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 20, 25, 
30, 40, 50, 75, 100 µM) in triplets. Results are presented as RPE. 
 
2.1.3 Cytotoxicity inMCF-7 cells 
Cytotoxicity of the fungicides was evaluated by using the Promega Cytotox 96 
Non Radioactive Cytotoxicity assay. Briefly, the MCF-7 cell proliferation 
assay was set up as usual for testing of estrogenicity or aromatase activity but 
with identical plates in pairs as the only difference. This was done to be sure 
that the assay passed as expected at the same time as the cytotoxicity could be 
measured. On the sixth day of exposure half of the plates were stopped as 
normal and the other half continued in the cytotoxicity assay. 
 
The cytotoxicity was assessed indirectly by measuring the stable cytosolic 
enzyme lactate dehydrogenase (LDH) released from damaged cells before 
and after lysis. The LDH activity was measured by an enzymatic assay where 
tetrazolium salt converts into a red formazan product and where the 
subsequent measured absorbance then corresponds to the number of lysed 
cells (Promega, 2001). The more cytotoxic a compound is the more LDH will 
be released during the six incubation days of the assay and the less will be 
released after lysis. The maximum release corresponds to the total release of 
LDH before and after lysis. The cytotoxicity was assessed by calculating the 
ratio: 
100%
_max
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∗=
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releaseeousspon
LDH
LDH
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Data will not be shown, but indicated in the relevant figures. 
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2.1.4 Androgen/anti-androgen testing – AR-assay 
Effects on AR activity were tested in a reporter gene assay (Vinggaard et al., 
1999) with minor modifications. Chinese Hamster Ovary cells (CHO K1) 
were maintained in DMEM/F12 (Gibco, Paisley, UK) supplemented with 
100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin B 
(Sigma-Aldrich, St.Louis, MO) and 10 % fetal bovine serum (FBS; 
BioWhitaker, Walkersville, MD). The cells were seeded in white 96-well 
microplates (PerkinElmer Life Sciences, Packard) at a density of 7,000 cells 
per well in DMEM/F12 containing 10 % charcoal-treated FBS (BioWhitaker) 
and incubated at 37°C in a humidified atmosphere of 5% CO2/air. After 24 h 
cells were transfected for 5 h with a total of 75 ng DNA per well consisting of 
the expression vector pSVAR0 and the MMTV-LUC reporter plasmid (both 
provided by Dr. Albert Brinkmann, Erasmus University, Rotterdam) in a ratio 
of 1:100 using 300 nl of the transfection reagent FuGene (Boehringer 
Mannheim, Germany). The ratio of DNA (µg) to Fugene (µl) was kept at 
0.25. The fungicides were tested in twelve concentrations ranging from 0.025 
to 50 µM, combined with 0.1 nM of the AR agonist R1881 (NEN, Boston, 
MA). The test solutions were prepared from 10 mM stock solutions in 
ethanol. After incubation for 20 h, the media was aspirated and the cells were 
lysed by adding 20 µl per well of a lysis buffer containing 25 mM 
trisphosphate, pH 7.8, 15 % glycerol, 1 % Triton X-100, 1 mM DTT and 8 
mM MgCl2, followed by shaking at room temperature for 10 min. Luciferase 
activity was measured directly using a Lumistar Galaxy luminometer by 
automatically injection of 40 µl substrate containing 1 mM luciferin 
(Amersham Int., Buckinghamshire, U.K.) and 1 mM ATP (Boehringer 
Mannheim, Germany) in lysis buffer  and the chemiluminiscense generated 
from each well was measured over a 1 sec interval. 
 
Cytotoxicity experiments were performed as described above, for the cell-
procedures and transfections, except that the pSVAR0 expression vector was 
replaced by the constitutively active AR expression vector pSVAR13 (a gift 
from Brinkmann), which lacks the ligand-binding domain of the receptor. 
The ratio between pSVAR13 and MMTV-LUC was 2:100. 
 
2.1.5 Ah receptor testing – CALUX assay 
The rat hepatoma H4IIE cells were stably transfected with the PAH/HAH-
inducible luciferase expression vector pGudLuc1.1. This vector contains the 
firefly luciferase gene under PAH/HAH-inducible control of four murine 
DREs (dioxin responsive elements) inducing luciferase in a time- and dose-
dependent manner (Garrison et al., 1996). 
 
H4IIE cells were grown in α-MEM medium with 5% FBS at 37˚C in 95% air 
and 5% CO2. Cells were seeded into sterile 96-well plates at 22.1 x 10
4 per ml 
and plates were incubated for 24 h prior to compound exposure, allowing 
cells to reach 90-100% confluence. Cells were exposed for 24 h to the azole 
fungicides (0, 0.2, 0.4, 0.8, 1.6, 3.1, 6.3, 12.5, 25, 50 µM) in α-MEM 
supplemented with 1% FBS. Following exposure, cells were washed twice 
with PBS (pH 7.4) and lysed in 20 µl lysis buffer. An aliquot of 10 µl 
supernatant was pipetted into a 96-well microtitre plate and luciferase activity 
was determined using a Lumistar Galaxy luminometer. 
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2.1.6 Steroid synthesis testing – H295R cells 
The H295R cell line, which is derived from human adrenocortical carcinoma 
cells, produces a wide range of steroid hormones in measurable quantities, 
including testosterone, progesterone and estradiol. This property makes the 
cell line suitable as a screening assay to detect effects on steroidogenesis. One 
alternative to the H295R cell line is the mouse Leydig tumour cell line 
MLTC-1. It produces progesterone, but only small amounts of testosterone 
and estradiol, which makes it less suitable as a screening assay to detect 
chemicals affecting steroid synthesis. 
H295R cells (ATCC, CRL-2128) established from a pluripotent human 
adrenocortical carcinoma cell line were grown in 24-well culture plates 
(Costar, Corning, NY, USA) at 37°C humidified atmosphere of 5% CO2/air. 
Each well contained 1 ml DMEM/F12 medium (GibcoBRL Life 
Tachnologies, Paisley, UK) supplemented with 2.0% Nu-serum (BD 
Sciences, Denmark), ITS+ premix (containing 6.25 µg/ml insulin, 6.25 g/ml 
transferin, 6.25 µg/ml selenuim, 1.25 µg/ml BSA and 5.35 µg/ml linoic acid) 
and 100 U/ml penicillin, 100 mg/ml streptomycin and 250ng/ml amphotericin 
B (Fungizone®). The cells were plated at a density of 2x105 cells/well and 
allowed to settle for 24 h. Culture medium was removed and new medium 
containing fungicide dissolved in dimethyl sulfoxid (DMSO) was added to 
the cells in triplicates (prochloraz: 0, 0.01, 0.03, 0.1, 0.3, 1, and 3 µM, 
epoxiconazole, propiconazole, and tebuconazole: 0, 0.1, 0.3, 1, 3, 10 and 30 
µM). Control wells contained the same amount of DMSO (0.1%) as exposed 
cells. After incubation for 48 h, the medium was removed and stored at -20°C 
until measured for testosterone, progesterone and estradiol levels. Samples of 
800 µl were concentrated on IST Isolute® SPE columns (100mg, C18, 1ml) 
(Hengoed, UK), and the steroid hormones were measured using Delfia kits 
(PerkinElmer Life Sciences, Turku, Finland). 
 
After exposure, the cells were incubated with resazurin solution to test for 
cytotoxicity. Medium from these wells (200µl) was transferred to black 
microplates (Costar, Corning, NY, USA) before fluorescence was measured. 
No cytotoxicity was observed for any of the concentrations used. 
 
2.1.7 Thyroid testing – GH3 thyroid assay (T-Screen) 
For the in vitro detection of agonistic and antagonistic properties of the azole 
fungicides towards the TR, the relatively new test method, called the T-
screen, was used. The assay is based on the thyroid hormone dependent cell 
growth of a rat pituitary tumor cell line (GH3). This cell line expresses 
intracellular TR in very high amounts, and the assay can be used to study 
interference of compounds with thyroid hormone at the cellular level. 
 
The GH3 cells were cultured at 37˚C humidified atmosphere of 5% CO2/95% 
air in DMEM/F12 (Gibco, Paisley, UK) supplemented with 100 U/ml 
penicillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin B (Sigma-
Aldrich, St.Louis, MO) and 10 % fetal calf serum (FCS)(Gibco, UK). Forty-
eight hours prior to plating the cells into 96-well microplates (Costar, Fisher 
Scientific Biotech Line) for the experiment, standard culture medium was 
changed to test medium containing 10% (v/v) T3- and T4-depleted dextran-
charcoal treated FCS (DC-FCS). After 48 h in DC-FCS, which was changed 
once after 24 h, the GH3 cells were released using a cellscraper and seeded in 
96-well black, clear bottom microplates, 50 µl cell suspension and 50 µl test 
compound per well, at a density of 2500 cells/well. The azole fungicides were 
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dissolved in DMSO, and all test solutions were prepared from 20 mM stock 
solutions, except the T3 stock solution, which was 10 mM. All four azole 
fungicides were tested in triplicates (epoxiconazole, prochloraz, 
propiconazole, and tebuconazole: 0, 0.01, 0.375, 1, 3, 10 and 30 µM) and 
were tested both in the absence and presence of 0.25 nM T3 (the reported T3-
EC50 by (Gutleb et al., 2005), to test for agonistic and antagonistic potency. 
Control wells contained cells and test medium with the same amount of 
DMSO (0.1%) as the exposed cells. The plates were incubated for 96 h, and 
cell growth was analyzed using AlamarBlue™ (BioSource, California, USA). 
10% (v/v) AlamarBlue was added to each well, and the plates were incubated 
4 h at 37˚C, protected from light. The experiment was terminated and the 
plates were analyzed by measuring fluorescence (ex. wavelength 560 nm/em. 
590 nm) on a Wallac Victor 1420 multilabel counter (PerkinElmer life Sciences, 
Turku, Finland). 
 
2.2 In vivo testing    
The second step in the investigation of endocrine disrupting properties of 
azole fungicides was to include animal studies. First a short-term animal study 
was conducted to study whether the azole fungicides were anti-androgenic in 
young adult rats. The results obtained in this study were used to design the 
following study in which pregnant rats were exposed to the fungicides to 
investigate endocrine disrupting effects on fetuses and offspring. This later 
assay is presently considered the most sensitive, but also a very comprehensive 
animal study, for testing of endocrine disruptors. 
 
2.2.1 Anti-androgenic testing – Hershberger test 
Male Wistar rats were acquired from Taconic M & B, Eiby, Denmark. 6 
intact male rats (42 days old at the dosing start) and 54 males, castrated at an 
age of 4 weeks, 14 days prior to study start, were used. All animals were 
delivered 1 week prior to study start and were upon arrival housed in Bayer 
Makrolon type 3118 cages (Type: 80-III-420-H-MAK, Techniplast), three 
per cage with Tapvai bedding. They were fed Syn 8.IT (a diet known to be 
free of phytoestrogens) and were provided with acidified tap water ad libitum. 
Animal rooms were maintained on a 12-hour light/dark cycle, a temperature 
of 22 ± 1 °C and a relative humidity of 55 ± 5 %. Rats were weighed and 
divided by randomization into treatment groups so that there were no 
statistically significant differences among group body weight means. During 
testing rats were weighed daily and visually inspected for health effects twice a 
day. 
 
One group of intact animals and 9 groups of castrated male Wistar rats, were 
included in the study (n=6 per group). The intact rats and the one group of 
castrated rats served as negative controls and were given peanut oil only. The 
rats in the remaining eight groups were all dosed with testosterone propionate 
(0.5 mg/kg/day sc). One group was only administered testosterone propionate 
and served as control group to which all other groups were compared.  The 
positive control group received flutamide (10 mg/kg bw/day orally). The last 6 
groups received propiconazole or tebuconazole orally at doses of 50, 100, or 
150 mg/kg bw/day. 
 
All compounds were dissolved in peanut oil. Sterile oil (the Royal Veterinary 
Agriculture Pharmacy, Copenhagen, Denmark) was used for the testosterone 
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propionate solution. All compounds were administered in a dosing volume of 
2 ml/kg body weight and the dosing period was 7 days for all animals. The 
testosterone dose was always given a few minutes after the test compound and 
the last dosing was performed in the morning at the day of killing the animals. 
Body weights were recorded and animals were euthanized using CO2/O2 
followed by exsanguinations. All the animals from each group underwent a 
thorough autopsy. The testis (for intact animals), both lobes of the ventral 
prostate, combined seminal vesicles and coagulating glands including fluids, 
levator ani/bulbocavernosus muscle (LABC), paired bulbourethral glands, 
pituitary, liver and paired kidneys were dissected and weighed. Organ weights 
were calculated relative to body weights. The ventral prostates were put in 0.5 
ml RNAlater (Ambion) and stored at -20°C until gene expression analysis. 
Blood was collected by heart puncture in plain glass tubes and serum was 
prepared and stored at -80°C until measurement of hormones. 
 
2.2.1.1 Hormone levels 
Rat luteinizing hormone (LH), rat follicle stimulating hormone (FSH), and T4 
levels were analyzed in serum using the technique of time-resolved 
fluorescence (Delfia, Wallac). LH and FSH were analyzed at Turku 
University, Finland. Rat FSH immunoreactivity was determined by a two-site 
immunofluorometric assay (IFMA) (van Casteren et al., 2000). The standard 
used was a NIDDK standard FSH-RP-2 obtained from the National 
Hormone and Pituitary Program, NIH, Rockville, MD. 
Rat LH was measured using the time-resolved fluorimetric assay (IFMA, 
Delfia, Wallac OY, Turku, Finland) as described (Haavisto et al., 1993). The 
standard rLH RP-3 was kindly provided by NIDDK, NIH (Baltimore, MD). 
 
2.2.1.2 Gene expression levels determined by real-time RT-PCR 
The organs were homogenized and total RNA was isolated using RNeasy-
mini kit and RNase-Free DNase set (Qiagen). cDNA was synthesized from 
0.5 µg total RNA using the Omniscript Reverse Transcription kit (Qiagen) 
with T16 oligoes and a 18S rRNA primer. Samples were quantified on the 
7900HT Fast Real-Time PCR System (Applied Biosystems) by standard 
TaqMan technology. Expression levels of the following genes were quantified, 
in the ventral prostate: The androgen-responsive genes prostate binding 
protein C3 (PBP C3), ornithine decarboxylase (ODC), testosterone-
repressed prostate message 2 (TRPM-2), complement component 3 (Compl. 
C3), the androgen receptor (AR) and insulin-like growth factor 1 (IGF-1). 
These genes were chosen because they have previously been shown to be 
androgen-regulated. PBP C3 is a tissue-specific protein and the principal 
secretory protein in rat prostatic fluid (see references in (Nellemann et al., 
2001)). ODC is necessary for cell growth and differentiation as an important 
enzyme in the synthesis of polyamines. ODC catalyzes the conversion of 
ornithine to putrescine, which is the first and rate-limiting step in polyamine 
biosynthesis. TRPM-2 also called clusterin, is not normally expressed in the 
rat ventral prostate, but is induced by castration (Leger et al., 1987). TRPM-
2 is expressed at high levels in dying cells, and data suggest that TRPM-2 acts 
as a survival factor from apoptosis (Ho et al., 1998;Ogawa et al., 2005;Viard et 
al., 1999). Compl. C3 is involved in the innate immune response and together 
with PBP C3, ODC and TRPM-2, this gene has been selected, because the 
expression of these four genes in ventral prostate, previously have been found 
to be valuable for investigating anti-androgenic effects in the Hersberger assay 
(Nellemann et al., 2001;Nellemann et al., 2005). For each sample, 2 µl cDNA 
(1.75 ng/µl) was amplified under universal thermal cycling parameters 
(Applied Biosystems) using TaqMan Fast Universal PCR Master Mix 
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(Applied Biosystems) in a total reaction volume of 10 µl. Three separate 
amplifications were performed for each gene and when intra-assay variation 
was above 10% additional amplifications were performed. All genes were 
quantified from standard curves, and expression levels of each target gene 
were normalized to the expression level of the housekeeping gene 18S 
ribosomal RNA (18S rRNA). Table 1 illustrates the sequences of the primers 
used. 
 
Table 1 - Sequences of the primers used for quantitative real-time PCR. 
 
18S rRNA 
5’-FAM-ACC GGC GCA AGA CGA ACC AGA G-TAMRA-3’ 
Forward, 5’-GCC GCT AGA GGT GAA ATT CTT G-3’  
Reverse, 5’-GAA AAC ATT CTT GGC AAA TGC TT-3’ 
 
PBP C3 
5’-FAM-TCA TCT AGA ATA CTG CAG CCA GAA CCA CTG G-TAMRA-3’  
Forward, 5’-CCA TCC CCA TTT GCT GCT AT-3’  
Reverse, 5’-AGT CAC AGT TGA GTT AAT TGT ACC TCT AAT AAC-3’ 
 
ODC 
5’-FAM-ACT CAC TGC TGT AAC ACA CAG CCT GTG CA-TAMRA-3’  
Forward, 5’-AAT GTG TGC AAG TAT CCC TTA CAG AA-3’  
Reverse, 5’-CAC AGC TTT GTA TCA TCC ACA TCT C-3’ 
 
TRPM-2 
5’-FAM-AGT TTC TGA ACC AGA GCT CAC CCT TCT ACT TCT G-
TAMRA-3’  
Forward, 5’-CTG GTT GGT CGC CAG CTA GA-3’  
Reverse, 5’-ATG CGG TCC CCG TTC AT-3’ 
 
Compl.C3 
5’-FAM-CGT AGT CCA CTC CAG GCT CAC AAG-TAMRA-3’  
Forward, 5’-CAG CCT GAA TGA ACG ACT AGA CA-3’  
Reverse, 5’-AAA ATC ATC CGA CAG CTC TAT CG-3’ 
 
IGF-1 
5’-FAM-CAA CAC TCA TCC ACA ATG CCC GTC T-TAMRA-3’ 
Forward, 5’-GAC CAA GGG GCT TTT ACT TC-3’ 
Reverse, 5’- GCA GCG GAC ACA GTA CAT CT-3’ 
 
AR 
5’-FAM-TCG CGA TTC TGG TAT GCT GCT GC-TAMRA-3’ 
Forward, 5’- GAC ACT TGA GAT CCC GTC CT-3’ 
Reverse, 5’- GAG CGA GCG GAA AGT TGT AG-3’ 
 
 
2.2.2 Developmental effects on offspring after perinatal exposure  
To test for developmental effects, pregnant dams were dosed with 
epoxiconazole or tebuconazole and the fetuses and offspring were examined 
for effects on sexual differentiation. Important biological endpoints were: 
gestational length, survival, anogenital distance (AGD) in fetuses and 
offspring, retention of nipples in male pups, decreased weight of accessory sex 
tissues, semen quality, morphological effects on the external genitalia 
(hypospadia and cryptorchidism), hormone levels, and gene expression. 
Figure 2 is a schematic overview of the study design. 
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2.2.2.1 Animals and exposure 
In short, 112 pregnant Wistar rats (HanTac: WH, Taconic M& B, Ejby, 
Denmark) were received on gestational day (GD) 3. The day after arrival, the 
animals were weighed and assigned to treatment groups (1-5) by stratified 
randomization to assure equivalent body weight means across groups prior to 
dosing. The rats were gavaged peanut oil (n=24), with 15 or 50 mg/kg bw/day 
epoxiconazole (n=24/24), or 50 or 100 mg/kg bw/day tebuconazole 
(n=20/20) respectively, from GD 7 to postnatal day (PND) 16. Animals were 
divided into two sets, such that 56 animals representing all 5 groups were 
dosed one week prior to the next 56 animals. In the 5 groups 19, 19, 18, 19 
and 21 rats, respectively, were pregnant.  
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• 
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Figure 2 - Schematic overview of the design of the developmental toxicity study. 
Pregnant dams were dosed GD7 to PND 16. At GD 21 some of the dams were chosen for 
caesarian section and the fetuses were investigated. Some of the dams were allowed 
to give birth (PND 0). At PND 16 some of the offspring were killed and tissue was taken 
for hormone- and gene expression analysis as well as pathology. Some of the 
offspring continued in the study for behavior tests (not included in this report) and 
semen quality tests (PND 224). 
GD: gestational day; PND: postnatal day; AGD: anogenital distance. 
 
2.2.2.2 Health status of dams and delivery 
The rats were observed twice daily for signs of toxicity. Body weight was 
registered daily from GD 7 to PND 16. The maternal weight gain from GD 7 
to GD 21, GD 7 to PND 1, and PND 1 to PND 13 was calculated from the 
data. The first measure is based on the weights of the dams including the 
weight of the fetuses and may therefore, if affected, reflect an effect on the 
maternal animal and/or the fetuses. In contrast, the maternal weight gain from 
GD 7 to PND 1 as well as the maternal body weight on PND 1 provides 
measures of the dam body weight only. From GD 21 the rats were inspected 
twice a day to register time of birth. After delivery body weights of dams and 
pups were recorded. Number of pups, sex ratio and anomalies were 
registered. The day of delivery is PND 0. 
 
2.2.2.3 Caesarian sections GD 21 
At GD 21 the following numbers of dams were originally selected for 
Caesaeian section: 6 controls; 7 dosed with 50 mg/kg bw/day and 8 dosed 
with 100 mg/kg bw/day tebuconazole; 9 dosed with 15 mg/kg and 14 dosed 
with 50 mg/kg epoxiconazole. However, because of problems with parturition 
in the highest dose groups, caesarian section was additionally performed on 2 
dams in the group receiving 100 mg tebuconazole/kg bw/day and on 4 dams 
in the group receiving 50 mg epoxiconazole/kg bw/day group. The dams were 
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weighed and decapitated after CO2/O2 anesthesia. Uterus was taken out, and 
the number of live fetuses, re-absorptions, implantations and any anomalies 
was registered. The remaining dams (13, 12, 8, 10 and 3 dams from the 
control, the 50 mg/kg and the 100 mg/kg tebuconazole, the 15 mg/kg and the 
50 mg/kg epoxiconazole group, respectively) were allowed to give birth. 
 
2.2.2.4 Section of pups PND 16 
At PND 16 all mothers and all pups except 72 pups, were killed and tissue 
was taken for hormone-, gene expression-, and pathology analysis. The 72 
remaining animals continued in the study for behavioral tests (not included in 
this report) and semen quality analysis (34 male pups). 
 
2.2.2.5 Histology and Immunohistochemistry GD 21 
In fetuses at GD 21 one testis from 1 to 3 males per litter were placed in 
Bouin’s fixative, embedded in paraffin and one section per male was used for 
histopathology (haematoxylin and eosin stain) or immunohistochemistry. 
Immunohistochemistry was performed on one section per testis. Following 
microwave pretreatment for 2x5 min in either citrate or TEG buffer, sections 
were blocked for endogenous peroxidase activity in 3% H2O2 in phosphate 
buffered saline (PBS), and blocked in 1% bovine serum albumin in PBS. 
Sections were incubated over night at 4˚C with the following rabbit polyclonal 
antibodies: Steroidogenic acute regulatory protein (StAR) antibody (PA1-
560, Affinity Bioreagents, Golden, CO, 1:1000), cytochrome P450-side-chain 
cleavage (P450scc) antibody (AB 1244, Chemicon, Temecula, CA, 
1:50,000), peripheral benzodiarepine receptor (PBR) antibody (SantaCruz, 
CA, 1:200), or 17β-hydroxysteroid dehydrogenase (17β-HSD) type 10 
(Kem-En-Tec). Sections were then incubated for 30 min with secondary 
antibody (Anti-rabbit EnVision+, DAKO, Glostrup, Denmark), stained in 
diaminobenzidine (DAB+ Substrate Chromogen System, DAKO, Glostrup, 
Denmark) or 3-amino-9-ethylcarbazole (AEC, Labvision, CA), and 
counterstained in Meyer’s hematoxylin. Negative controls were fetal control 
testis, incubated with blocking serum instead of primary antibody. 
 
2.2.2.6 Hormone analysis GD 21 and PND 16 
Testosterone, progesterone, 17α–hydroxy-progesterone, estradiol and thyroid 
hormones were analyzed in rat plasma or testes at GD21 and/or PND 16. 
Steroid hormones were extracted from the serum on IST Isolute C18 SPE 
columns (200mg/3ml). The serum samples were diluted with purified water 
1:1 and applied to columns, preconditioned and rinsed with methanol 
(MeOH) and water, respectively. Interfering substances were eluted with 2x2 
ml MeOH:water (20:80 v/v) and steroids were eluted with 2x2.4 ml MeOH. 
The solvent in these fractions was evaporated and samples were resuspended 
in 100 µl Diluent 1 (PerkinElmer, Turku, Finland) and the steroids together 
with the thyroid hormones triiodothyronine (T3) and thyroxine (T4) were 
analyzed using a Delfia time-resolved fluorescence kit (PerkinElmer, Turku, 
Finland) and measured by use of a Wallac Victor 1420 multilabel counter 
(PerkinElmer life Sciences, Turku, Finland). 
 
Steroid hormones were analyzed in testis and estradiol in ovaries after 
extraction with diethyl ether. Decapsulated testes or ovaries were placed in 
vials containing 100 or 500 µl water and 0.5 or 2.5 ml diethyl ether, 
respectively. The tissue was homogenized and the vials were placed in a tub 
consisting of dry ice and acetone until the water-fraction was frozen. The 
ether-fraction was transferred to a clean vial, the procedure was repeated, and 
the two extracts were pooled and evaporated. Before analyzing, the samples 
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were re-suspended in 100 µl Diluent 1 and incubated over night at 4˚C. The 
day of analysis the samples were vortexed and incubated for 10 min at 45˚C, 
before the hormones were measured by use of the Delfia kit as mentioned 
above. 
Ex vivo testosterone and progesterone production at GD 21 was determined 
by decapsulating and incubating the testis in a shaking water bath at 34˚C for 
3 h in DMEM/F12 medium containing 0.1 % BSA. Vials were centrifuged at 
4000 x g for 10 min and the supernatants were stored at -80˚C until hormone 
levels were analyzed as mentioned above. Testosterone levels were measured 
in undiluted supernatant, but for the measurement of the progesterone levels 
the supernatants were concentrated 5 times by the use of IST Isolute C18 
SPE columns and resuspended in 100 µl Diluent 1. 
 
2.2.2.7 Gene expression levels GD 21 and PND 16 
The following genes were studied in testes at GD 21: scavenger receptor class 
B, member 1 (ScarB1), StAR, P450scc and Cyp17a1 (P450c17). In the testis 
ScarB1 transports serum lipoproteins (HDL) into the testis Leydig cell, where 
they are used in the synthesis of cholesterol. StAR transports the cholesterol 
from the outer to the inner mitochondrial membrane where the first enzyme 
in steroid synthesis, P450scc, is located, which converts cholesterol to 
pregnenolone. P450c17 is involved in several of the steps that convert 
pregnenolone to testosterone, and functions both as a 17α–hydroxylase and a 
17,20-lyase (Felig et al., 1995) (Figure 3). 
 
At PND 16 the following genes were studied in ventral prostate: AR, ODC, 
Compl. C3, IGF-1, PBP C3, and TRPM-2. In the epididymides the 
expression level of the placenta and embryos oncofetal gene (PEM) was 
quantified. PEM is a home-domain-containing protein, proposed to play a 
role in the regulation of androgen-dependent events in the epididymis.  
 
Each sample was processed as previously described in section 2.2.1.2 and all 
genes were quantified from standard curves, and expression levels of each 
target gene were normalized to the expression level of the housekeeping gene 
18S rRNA. See Table 2 for primer sequences used for the quantitative real-
time PCR in testis and epididymis. 
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Figure 3 - Illustration of the pathway of testicular testosterone synthesis. The uptake 
of cholesterol and its conversion to testosterone involves numerous receptors and 
enzymes, including ScarB1, which is responsible for HDL uptake into Leydig cells, StAR 
that transport the cholesterol from the outer to the inner mitochondrial membrane 
and the steroid-converting enzymes P450scc and P450c17, which are involved in the 
conversion of cholesterol to testosterone. 
 
2.2.2.8 Anogenital distance and nipple retention 
AGD was measured in the offspring at birth (PND 1) using a 
stereomicroscope. On PND 13, the male pups were examined for the 
presence of areolas/nipples, described as a dark focal area (with or without a 
nipple bud) located where nipples are normally present in female offspring. 
To correlate for the size of the pups their body weights were measured at both 
time points (PND 1 and PND 13). AGD is expressed per cube root of body 
weight since this ratio has been demonstrated to be the most appropriate 
metric for normalizing of the data (Gallavan, Jr. et al., 1999). 
 
2.2.2.9 Autopsy of offspring on PND 16 
The external genitalia were inspected blinded to the observer at PND 16 in all 
males from all litters. The changes were scored on a scale from 1 to 4 in order 
to investigate whether male external genitals were feminized. The following 
criteria were used: Score 1: No effect: normal genital tubercle, the urethral 
opening is found at the tip of the genital tubercle and the preputial skin is 
intact. In the perineal area, thick fur extends caudally from the base of the 
genital tubercle half the distance to the anus. A furless area circumscribes the 
anus. Score 2: Mild dysgenesis of the external genitalia: A small cavity on the 
caudal surface of genital tubercle and a minor cleft in the preputial opening is 
observed, estimated 0.5-1.4 on an arbitrary scale. The furless area around 
anus expands towards the base of the genital tubercle, but thick fur is still 
present at the base of the genital tubercle. Score 3: Moderate dysgenesis of the 
external genitalia: the preputial cleft is larger, estimated 1.5-2.4 on an 
arbitrary scale. The urethral opening is situated half way down the inferior 
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side of the genital tubercle (hypospadia). Lack of fur or thin fur in the 
perineal area ranging from the base of the genital tubercle and caudally to the 
furless area circumscribing the anus. Score 4: Severe dysgenesis of the 
external genitalia: The preputial cleft is large, estimated 2.5-3.5 on an 
arbitrary scale. The urethral opening is situated further than half way down 
the inferior side of the genital tubercle to the base of the genital tubercle. At 
the base of the genital tubercle a groove extending laterally is observed, and 
they are totally furless in the whole perineal area. 
 
Table 2 - Sequences of the primer used for quantitative real-time PCR in testis and 
epididymis. 
 
ScarB1 
5’-FAM- AAA GCA TTT CTC CTG GCT GCG CAG-TAMRA-3’ 
Forward, 5’-TCT GGT GCC CAT CAT TTA CCA-3’ 
Reverse, 5’- AGC CCT TTT TAC TAC CAC TCC AAA-3’ 
 
StAR 
5’-FAM- CTG ACT CCT CTA ACT CCT GTC TGC CTA CAT GGT-
TAMRA-3’ 
Forward, 5’- CCC TTG TTT GAA AAG GTC AAG TG-3’ 
Reverse, 5’- TGA AAC GGG AAT GCT GTA GCT-3’ 
 
P450scc 
5’-FAM- CCT TTA TGA AAT GGC ACA CAA CTT GAA GGT ACA-
TAMRA-3’ 
Forward, 5’- ACG ACC TCC ATG ACT CTG CAA T-3’ 
Reverse, 5’- CTT CAG CCC GCA GCA TCT-3’ 
 
P450c17 
5’-FAM- CGT CAA CCA TGG GAA TAT GTC CAC CAG A-TAMRA-3’ 
Forward, 5’-GCC ACG GGC GAC AGA A-3’ 
Reverse, 5’- CCA AGC CTT TGT TGG GAA-3’ 
 
PEM 
5’-FAM- CCATCTATCAAGCTCCTCCCGCCACT-TAMRA-3’ 
Forward, 5’- CAT TTT GCT AAG CAG TGG TTC CT-3’ 
Reverse, 5’- CCT GCA CTC TGG ACA CAC TGA-3’ 
 
For the primer sequences used in the quantification of: 18S rRNA, PBP C3, ODC, TRPM-2, 
Compl.C3, IGF-1 and AR see Table 1. 
 
2.2.2.10 Organ weight and histopathology PND 16 
Body weights of all male pups were recorded. In one to two male per litter the 
following organs were excised and weighed: liver, kidneys, adrenals, testes, 
epididymides, seminal vesicles, ventral prostate, bulbourethal glands, and 
LABC. In the analysis of body and testis weight, generally one to four males 
per litter were used. 
 
From one or two males per litter, the right or left testes were alternately fixed 
in Bouin’s fixative, paraffin embedded, and stained with hematoxylin and 
eosin. In one male per litter, the following organs were fixed in formalin: 
ventral prostate, seminal vesicles, and epididymides. All fixed organs were 
embedded in paraffin and examined by light microscopy after staining with 
hematoxylin and eosin and used for the histopathological evaluation. 
 
In one to two females per litter, body weights were recorded. The thyroid, 
ovaries and uterus were excised and weighed from one female per litter. 
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2.2.2.11 Semen quality analysis PND 224 
Due to toxicity in the highest dose groups, none of the high dose animals were 
available for the semen quality analysis. Semen quality was therefore only 
analyzed in the controls and the low dose groups of tebuconazole and 
epoxiconazole, using 11-12 male offspring per group at the age of 
approximately 7 months. The animals were anaesthetised by CO2/O2 and 
decapitated. The epididymis were removed and the cauda of the right 
epididymis was used for sperm motility analysis. 
 
2.2.2.12 Sperm motility 
The epididymis was trimmed of fat and cut at the corpus-cauda region. The 
cauda was placed in a petri dish containing 3 mL warm (37ºC) Medium 199, 
supplemented with 0.5% bovine serum albumin (crystallized and lyophilized; 
Sigma Chemicals Company, USA). Spermatozoa were obtained from the 
distal cauda where the tubular diameter was widest. Under the dissecting 
microscope, the cauda was held by forceps and several stabs were made into 
the tubules. The petri dish was placed in an incubator for 5 min. The cauda 
was removed and the sperm sample was diluted 10 times (in medium 199, 
supplemented with 0.5% bovine serum) and replaced in the incubator for 10 
min, to allow dispersion of the spermatozoa. The sperm sample was loaded 
into a 100-µm flat cannula (HTR 1099, DIPL.ING. HOUM, Norway) and 
analyzed by computer assisted sperm analysis (CASA; HTM-IVOS version 
10.6, Hamilton Thorne Research, Beverly, MA, USA). Several fields 
(minimum 20) were recorded at 60 Hz under 4× dark field illumination, and 
the images were video recorded for later analysis. 
 
The standard set-up was used during analysis and tracking errors were deleted 
through the edit and playback features. Twelve fields (minimum 200 sperm 
cells) were analyzed for each sperm sample. The parameters evaluated in this 
study were percent motile and percent progressive spermatozoa, curvilinear 
velocity (VCL), and amplitude of lateral head displacement (ALH), which 
describes the vigour of the spermatozoa, and progression parameters such as 
average path velocity (VAP), straight-line velocity (VSL), and straightness 
(STR). 
 
2.3 Statistical analyses 
2.3.1 In vitro and in vivo Hershberger test 
Data did not deviate from normality or homogeneity of variance. Data were 
analyzed by one-way ANOVA followed by pair-wise comparisons between 
test and control groups using Dunnetts test. Significance was judged at 
p<0.05. 
 
2.3.2 Developmental Study 
The litter was generally considered the statistical unit and the alpha level was 
0.05. The results were analyzed by analyses of variance (ANOVA), and in 
order to adjust for litter effects, litter was included in the analysis of variance 
as a nested factor. 
 
For statistical evaluation of testosterone and progesterone levels in testes (2 - 4 
males per litter) and ex vivo testosterone and progesterone production GD 21 
(3 -11 males per litter), all males were included in the analysis. Data from one 
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male and one female per litter at PND 16 (12-16 litters per group) and one or 
two males per litter at PND 224 (11-16 litters per group leading to a total of 
16 animals per group) were used to analyze terminal body weight and organ 
weights. In order to adjust for litter effects, litter was included in the analysis 
of variance as an independent, random, and nested factor (proc mixed, SAS 
version 8, SAS Institute Inc, Cary, NC, USA). Organ weights were analyzed 
using treatment as one main factor and age as another main factor and body 
weight was used as a covariate. Non-processed and ln-transformed data were 
examined for normal distribution and homogeneity of variance. If an 
interaction between age groups and dose group was observed, the age groups 
were analyzed separately. When an overall significant treatment effect was 
observed, two-tailed comparison was performed using least square means. In 
cases where normal distribution and homogeneity of variance was not 
obtained, data were additionally tested with the non-parametric Wilcoxon 
Scores followed by a Kruskall-Wallis test. 
 
Plasma hormone data were anayzed by a one-way ANOVA and, if significant, 
followed by Dunnett’s test. Significance was judged at p < 0.05. Sperm data 
were examined for normal distribution and homogeneity of variance. Single 
animal data were analyzed in a one-way analysis of variance (proc glm) 
followed by Dunnett`s t-test (version 8, SAS Institute Inc, Cary, NC, USA). 
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3 Results - Endocrine disrupting 
effects of azole fungicides 
3.1 In vitro effects 
To investigate the endocrine disrupting mechanisms involved, the four azole 
fungicides: epoxiconazole, prochloraz, propiconazole, and tebuconazole were 
tested in a range of in vitro test systems to evaluate anti/estrogenicity, 
anti/androgenicity, dioxin like effects, disruption of the thyroid function, and 
effects on aromatase activity and other enzymes involved in the steroid 
synthesis. 
 
3.1.1 Estrogenic/anti-estrogenic effects of azole fungicides 
Figure 4 illustrates that all four fungicides inhibited MCF-7 cell proliferation 
induced by 10 pM 17β-estradiol and hence exhibited weak anti-estrogenic 
responses. The response was statistically significant from 1.6 µM (Table 3). 
Concentrations causing 25%, 50%, and 75% inhibition of the 17β-estradiol 
induced (10 pM) MCF-7 cell proliferation response (IC25 , IC50, IC75) were 
calculated (Table 3). IC50 values were found to be 49, 28, 52, and 45 µM for 
epoxiconazole, prochloraz, propiconazole, and tebuconazole, respectively. 
Prochloraz was the most potent of the four fungicides. 
 
Table 3 - Concentrations (µM) of the fungicides causing 25, 50, or 75 % inhibition of 
the 17β-estradiol (10 pM) induced MCF-7 cell proliferation response. 
 
       Epoxiconazole        Prochloraz  Propiconazole   
 Tebuconazole    
 
LOEC   25                12.5                     25                       1.6  
IC25   36   21   40   32 
IC50   49   28   52   45 
IC75   66   38   64   63 
 
LOEC: Lowest observed effect concentration. LOEC is chosen as the lowest concentration causing 
a continuously statistically significant response.  
 
Since a decreased proliferation can be due to general cell toxicity of the 
fungicides in the MCF-7 cells, a LDH-test for cytotoxicity was performed. 
Cytotoxicity was only detected at the highest azole concentrations (indicated 
by a c in the figures) and cannot explain the decreased cell proliferation of the 
azole fungicides at lower concentrations. 
 
In addition, epoxiconazole and propiconazole increased the cell proliferation 
indicating a weak estrogenic activity (Figure 5). This activity was statistically 
significant at 6.25 and 25 µM, respectively. 
 
Experiments with the well-known anti-estrogenic compound ICI 182.780 (1 
nM) revealed that the cell proliferation induced by these fungicides was 
counteracted by ICI 182.780, thus, indicating that the proliferation is induced 
directly via the ER receptor (data not shown). 
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Figure 4 - Anti-estrogenic effects of the four fungicides: epoxiconazole, prochloraz, 
propiconazole, and tebuconazole tested in the MCF-7 cell proliferation assay. All 
four fungicides inhibited the proliferation of MCF-7 cells induced by 10 pM 17β-
estradiol. Data represent mean±SD for three to seven independent experiments. The 
horizontal gray line represents the control level and the dashed gray lines 
represent the SD of the control. ∗ Statistically significantly different from control 
(10 pM 17β-estradiol) (p<0.05). c = tested cytotoxic by use of a LDH-test. RPE = Relative 
Proliferative Effect. 
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Figure 5 - Estrogenic effects of the four fungicides: epoxiconazole, prochloraz, 
propiconazole, and tebuconazole tested in the MCF-7 cell proliferation assay. 
Epoxiconazole and propiconazole induced proliferation of the MCF-7 cells. Data 
represent mean±SD for three to seven independent experiments. The horizontal gray 
line represents the control level and the dashed gray lines represent the SD of the 
control. ∗ Statistically significantly different from control (p<0.05). c = tested 
cytotoxic by a LDH-test. RPE = Relative Proliferative Effect. 
 
3.1.2 Aromatase effects of azole fungicides 
Figure 6 illustrates that all four fungicides inhibit the 1µM testosterone-
induced MCF-7 cell proliferation. The effect is statistically significant from 1 
µM. The response obtained in this assay will be the combined effect of 
aromatase inhibition and anti-estrogenicity as aromatase converts testosterone 
to estrogen, which then induces proliferation of the cells. 
 
Concentrations causing 25%, 50%, and 75% inhibition of the 1 µM 
testosterone induced MCF-7 cell proliferation response (IC25, IC50, IC75) were 
calculated (Table 4). IC50 values were found to be 17, 9, 29, and 19 µM for 
     Epoxiconazole                                                                         Prochloraz 
      Tebuconazole Propiconazole 
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epoxiconazole, prochloraz, propiconazole, and tebuconazole, respectively. 
Prochloraz was the most potent among the four (Table 4). 
 
The concentrations of the azole fungicides needed to reduce the testosterone-
induced response were lower than the concentrations needed to reduce the 
17β-estradiol-induced response. This indicates that these compounds possess 
both aromatase inhibiting and anti-estrogenic properties but that aromatase 
inhibition dominates at low concentrations. 
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Figure 6 - Effects on the enzyme aromatase of the four fungicides: epoxiconazole, 
prochloraz, propiconazole, and tebuconazole tested in the MCF-7 cell proliferation 
assay. All four fungicides inhibited the 1 µM testosterone (converted by aromatase to 
estrogen) induced MCF-7 cell proliferation. Data represent mean±SD for three 
independent experiments. The horizontal gray line represents the control level and 
the dashed gray lines represent the sd of the control. ∗Statistically significantly 
different from control (1 µM testosterone) (p<0.05). c = tested cytotoxic by a LDH-test. 
RPE = Relative Proliferative Effect. 
 
Table 4 - Concentrations (µM) of the fungicides causing 25, 50, or 75 % inhibition of 
the testosterone-induced (1 µM) MCF-7 cell proliferation response. 
 
     Epoxiconazole   Prochloraz    Propiconazole  Tebuconazole 
 
LOEC    1             1    10   10 
IC25    4    3   16    6   
IC50   17    9   29   19 
IC75   73   25   53   60 
 
LOEC: Lowest observed effect concentration. LOEC is chosen as the lowest concentration causing 
a continuously statistically significant response. 
 
     Epoxiconazole                                                       Prochloraz 
 Tebuconazole Propiconazole 
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3.1.3 Anti-androgenic effects of azole fungicides 
All four azole fungicides proved to be AR antagonists. No cytotoxicity was 
observed except for prochloraz and tebuconazole that were cytotoxic at 50 
µM (data not shown). As shown in Figure 7 all the azole fungicides had a 
potency of comparable magnitude. The LOECs were 0.8, 3.1, 25 and 3.1 µM 
for epoxiconazole, prochloraz, propiconazole, and tebuconazole respectively. 
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Figure 7 - Anti-androgenic effects determined in the AR reporter gene assay. The 
fungicides are tested in combination with the AR agonist R1881 in AR transfected CHO 
cells. Data represent mean±SD for three independent experiments.  * Significance 
level p < 0.05 compared to the control (0.1 nM R1881). 
 
3.1.4 Dioxin-like effects of azole fungicides – Ah-receptor testing 
Like prochloraz (Long et al., 2003) epoxiconazole, propiconazole, and 
tebuconazole were able to activate the Ah receptor (Figure 8), but far from 
the order of magnitude displayed by prochloraz. The LOECs were 6.3, 0.05, 
12.5 and 6.3 µM for epoxiconazole, prochloraz, propiconazole, and 
tebuconazole, respectively (Table 5). 
 
Table 5 - Concentrations (µM) of the fungicides needed to induce a significant 
response in the AhR CALUX reporter gene assay, and the effect of the fungicides in 
relation to the maximum response induced by the AhR agonist TCDD. 
 
             Epoxiconazole  Prochloraz   Propiconazole 
 Tebuconazole           
   
 
LOEC      6.3   0.05   12.5    6.3             
MOEC      50   10   50  
 50            
% Effect of max. TCDD effect   9   38   10     
8  
 
LOEC: Lowest observed effect concentration. LOEC is chosen as the lowest concentration causing 
a continuously statistically significant response. MOEC: Maximum observed effect concentration: 
the lowest concentration causing maximum response. 
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Figure 8 - Agonistic effect measured in the AhR CALUX reporter gene assay. Concentration 
response curves for the four fungicides epoxiconazole, prochloraz, propiconazole, and 
tebuconazole and for the AhR agonist TCDD. For concentrations above 10 µM a decrease of 
luciferase activity was seen for prochloraz, which is due to a cytotoxic effect. * The prochloraz data 
is from a previous conducted study in 2002. 
 
3.1.5 Steroid synthesis effects of azole fungicides 
In order to look for effects on steroidogenesis in vitro, we tested 
epoxiconazole, prochloraz, propiconazole and tebuconazole in the H295R 
steroid synthesis assay, and compared it to the results of the previously 
conducted study with prochloraz (Laier et al., 2006). 
 
Epoxiconazole, propiconazole, and tebuconazole, were like prochloraz able to 
inhibit the production of testosterone and estradiol in vitro in H295R cells, 
though the inhibiting effect on testosterone production was only statistically 
significant for the two highest concentrations of tebuconazole. The estradiol 
production was statistically significantly inhibited at the two highest 
concentrations of tebuconazole, and the tree highest concentrations of 
epoxiconazole (Figure 9). Regarding effects on progesterone synthesis, the 
general picture was a stimulating effect, but at the highest concentrations of all 
fungicides the stimulation was decreased (Figure 9). Cytotoxicity was not 
found at any concentrations using the resazurin-test. 
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Figure 9 - In vitro effects of the fungicides on testosterone, progesterone and 
estradiol formation in human adrenocortical carcinoma cells (H295R). Data 
represent the mean±SEM for two to three independent experiments. E2 = estradiol. * 
Statistically significantly different from control (P<0.05). 
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3.1.6 Thyroid effects of azole fungicides 
The effect on proliferation of GH3 rat pituitary tumor cells in vitro by T3 and 
the fungicides is illustrated in Figure 10 and 11, respectively. T3 dose-
dependently stimulated the cell proliferation at 0.05 nM (LOEC) and 
maximally at 1.5 nM (MOEC) (Figure 10). The half maximum response 
(EC50) of T3 was determined at 0.20 nM. This assay was established as part of 
this project and the fact that we get a nice dose-response curve for T3 verifies 
that the assay works. 
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Figure 10 - Effect of T3 on proliferation of GH3 cells. Solvent control (0.1% DMSO) 
was set to 0 %. 
 EC50 determined to 0.20 nM. Data represent mean±SD for three independent 
experiments. 
 
Propiconazole and tebuconazole had a weak inhibitory effect on GH3 cell 
growth (Figure 11). At concentrations of 3 µM to 30 µM tebuconazole 
statistically significantly decreased the cell proliferation to approximately 70% 
of basal level and propiconazole significantly decreased the cell proliferation at 
30 µM to approximately 80% of solvent control. 
 
Tebuconazole significantly inhibited the T3-induced growth of the GH3 cells 
at 10 and 30 µM, and for the three other pesticides a significant decreased cell 
growth was also seen at 30 µM (Figure 11). The decrease in cell proliferation 
at 30 µM, for cells treated with the fungicides alone as well as upon co-
treatment 0.25 nM T3, is probably due to a cytotoxic effect, as others have 
demonstrated cytoxicity at these concentrations, for some of the same 
chemicals (Ghisari and Bonefeld-Jorgensen, 2005). 
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Figure 11 - Effects of the fungicides in the T-screen assay: GH3 cells treated with 
different concentrations of fungicides alone (a) or in the presence of 0.25 nM T3 (b). 
The values are given as percentage of the proliferation of solvent control (0.1% 
DMSO) or of positive control (0.25 nM T3). Data represent mean±SD. * Statistically 
significantly different (p ≤ 0.05 ) from the respective controls. 
 
3.2 In vivo effects 
A Hershberger test and a developmental toxicity study were conducted to 
investigate in vivo effects of the azole fungicides.   
 
3.2.1 Anti-androgenic effects in the Hershberger test 
Propiconazole and tebuconazole were tested in castrated testosterone-treated 
rats in order to determine if the compounds were able to block androgen 
receptors or affect androgen levels in vivo. They were administered orally at 
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doses of 50, 100, and 150 mg/kg together with a sc injection of a fixed dose of 
testosterone. The anti-androgen flutamide was given as a positive control. 
 
In vivo, body weights, paired kidney weights, thyroid and pituitary weights 
were unaffected by the treatments, whereas liver weights were increased with 
both fungicides. The increase in liver weights was statistically significant at the 
highest dose of tebuconazole and the two highest doses of propiconazole. 
 
Compared to intact males of the same age, castrated vehicle-exposed rats had 
significantly reduced weights of all the reproductive organs and increased 
levels of LH and FSH (Table 6 and 7). The serum levels of T4 were 
unaffected by castration. On the gene expression level both PBP C3 and 
ODC mRNA were reduced by castration, whereas TRPM-2 and Compl. C3 
mRNA were increased (Table 8). All these results were in accordance with 
predictions based on theoretical knowledge and previous experiments. 
 
Flutamide exerted the expected effects as well, and caused qualitatively the 
same effects as seen after castration. The weights of all reproductive organs 
were decreased; serum LH and FSH levels were increased and at gene level 
both PBP C3 and ODC mRNA were reduced, whereas TRPM-2 and Compl. 
C3 mRNA were increased. Overall it can be concluded that this Hershberger 
test was performed as expected. 
 
The fungicides had no effect on neither reproductive organ weights or on 
hormone levels, except for the highest dose of propiconazole, for which there 
was a significant increase in FSH. On the gene expression level, the only 
significant effect of the fungicides was a decrease in the level of ODC mRNA 
in prostate, with all doses of propiconazole and with the highest dose of 
tebuconazole. This gene is regulated by androgens but is also regulated via 
other pathways, so in the light of the lack of anti-androgenic effects on other 
genes, it is conceivable that this effect is due to a non-androgen dependent 
effect. 
 
In conclusion neither propiconazole nor tebuconazole had any androgen 
receptor blocking effects in vivo in the Hershberger test at doses below 150 
mg/kg bw/day. This is in contrast to the imidazole fungicide prochloraz that 
induced anti-androgenic effects at doses between 50 and 150 mg/kg bw/day. 
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3.2.2 Effects on offspring after prenatal exposure 
Developmental effects of epoxiconazole and tebuconazole were investigated 
by dosing pregnant dams with test compounds and examination of their 
fetuses and offspring for effects on sexual differentiation. 
 
3.2.2.1 Effects on GD 21 fetuses 
As seen from Table 9 the highest dose of tebuconazole lead to a decreased 
body weight gain in dams, probably due to effects on both the dam and the 
uterine content, increased loss of fetuses and decreased fetal weight on GD 
21. The highest dose of epoxiconazole caused increased loss of fetuses and 
decreased fetal weight in the absence of effects on maternal weight gain. Many 
of the dead fetuses (27 of 128) had died very late in the gestation period, 
while such late fetal death was not seen in the controls (0 of 70). The lower 
dose of epoxiconazole also seemed to induce increased fetal death, but the 
differences were not statistically significant. Very late fetal death occurred in 4 
out of 92 cases compared to 0 in the controls. Although not statistically 
significant these findings raise concern for effects on fetal survival also at this 
dose level. 
 
3.2.2.2 Immunohistochemistry 
StAR and P450scc immunostaining were comparable to controls. However, it 
cannot be excluded that effects on PBR and 17β HSD immunostaining were 
present, but due to lack of control foetuses for this analysis, no conclusions 
could be made. 
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Table 9 - Pregnancy and litter data for the developmental study. 
  Control 
 Tebuconazole 
50 mg/kg 
 Tebuconazole  
100 mg/kg 
Epoxiconazole 
15 mg/kg 
 Epoxiconazole 
50 mg/kg 
Dams and litters      
No. of dams (viable litters) N=13 (13) N=12 (12) N=10 (8) ¤ N=10 (9) N=7 (1-2) ¤ 
BW gain. GD7-GD21 (g) 85.38 ± 11.9 77.17 ± 14.4 61.00±12.5* 87.70 ± 16.1 92.14 ± 14.0 
BW gain. GD7-PND1 (g) 20.62 ± 7.2 17.58 ± 6.8 13.50 ± 10.6* 18.11 ± 6.7 15.00 ± 8.5 
BW gain PND1-PND13 (g) 7.53 ± 16.3 7.75 ± 16.84  -4.57 ± 12.9  -6.89 ± 24.8 20 
Gestation length (d) 22.46 ± 0.5 22.67 ± 0.5 23.40 ± 1.2** 22.67 ± 0.7 23.71 ± 0.8** 
% postimplantation loss 6.55 ± 5.1 10.31 ± 11.2 27.32 ± 23.5* 16.01 ± 30.0 34.25 ± 18.2* 
% perinatal loss   9.67 ± 8.0 13.37 ± 12.5 54.97 ± 36.9** 18.21 ± 30.0 88.78 ± 29.7** 
Litter size  11.15 ± 1.7 10.75 ± 3.6 8.75 ± 3.8 9.90 ± 4.1 8.67 ± 3.1 
Born alive per litter 10.92 ± 1.7 10.67 ± 3.7 8.38 ± 3.8 9.80 ± 4.0 4.33 ± 5.9** 
Born dead per litter 0.23 ± 0.4 0.08 ± 0.3 0.37 ± 0.7 0.10 ± 0.3 4.33 ± 2.9** 
% PN death 3.39 ± 5.55 3.36 ± 7.04 27.00 ± 37.5* 2.78 ± 5.9 69.44 ± 52.9** 
% males 44.76 ±17.6 56.42 ± 11.7 40.36 ± 18.6 45.45 ± 13.13 34.72 ± 33.42 
Offspring (data from viable litters)     
Birth weight (g) 5.53 ± 0.3 5.64 ± 0.5 5.63 ± 0.8 6.21 ± 0.6** 6.36 ± 0.3 
BW. PND 13 (g) 23.25 ± 2.6 21.59 ± 4.14 22.39 ± 5.02 21.48 ± 4.8 23.4 
Male AGD (mm) 3.41 ± 0.2 3.39 ± 0.1 3.51 ± 0.2 3.65 ± 0.22* 3.41 ± 0.3 
Male AGD/cuberoot bw 1.92 ± 0.1 1.90 ± 0.1 1.96 ± 0.1 1.96 ± 0.1 1.83 ± 0.2 
Female AGD (mm) 1.72 ± 0.1 1.80 ± 0.1 1.91 ± 0.1* 1.95 ± 0.2** 1.71 
Female AGD/cuberoot bw 0.98 ± 0.03 1.02 ± 0.06 1.09 ± 0.07* 1.08 ± 0.08* 0.96 
No. aerolas in males 2.08 ± 0.6 3.43 ± 0.9** 3.07 ± 2.5** 2.53 ± 1.1 3.38 
No. aerolas in females 12.5 ± 0.4 12.46 ± 0.4 12.31 ± 0.4 12.32 ± 0.2 12 
GD21 Caesarian section ¤      
No. of dams N=6 N=7 N=8+2 ¤ N=9 N=14+4 ¤ 
Maternal bw  (g) 307.17 ± 22.4 297.00 ± 27.2 281.00 ± 26.5* 287.33 ± 29.8 285.73 ± 17.7 
Adjusted bw (g) 232.70 ± 14.9 234.00 ± 16.8 223.31 ± 20.4 231.49 ± 15.9 223.13 ± 21.0 
No. implantations 12.50 ± 2.1 12.00 ± 3.2 11.60 ± 1.5 10.22 ± 4.3 12.06 ± 2.4 
No. fetuses 11.67 ± 2.1 11.14 ± 3.6 9.40 ± 2.1 9.11 ± 4.9 9.00 ± 4.1 
% postimplantation loss  6.45 ± 7.9 9.10 ± 11.3 21.54 ± 9.4* 20.87 ± 33.5 28.14 ± 26.9* 
% late res 1.28 ± 3.1 2.38 ± 6.3 6.14 ± 4.2 13.89 ± 33.3 24.88 ± 27.3* 
% very late res  0.0 ± 0.0 2.38 ± 6.3 2.39 ± 4.2 4.16 ± 11.8 15.12 ± 24.0* 
% males 56.01 ± 17.2 46.22 ± 20.9 49.74 ± 20.6 46.41 ± 18.8 53.57 ± 25.3 
Fetal weight male (g) 4.45 ± 0.3 3.84 ± 0.7 3.44 ± 0.9** 3.98 ± 0.9 3.79 ± 0.7* 
Fetal weight female (g) 4.18 ± 0.4 3.61 ± 0.6 3.40 ± 0.9* 3.83 ± 0.8 3.54 ± 0.7* 
No. litters for  AGD # N=3 N=4 N=4 N=6 N=10 
Male AGD (mm) 3.39 ± 0.3 3.50 ± 0.03 3.29 ± 0.4 3.54 ± 0.1 3.40 ± 0.1 
Male AGD /cuberoot bw 2.08 ± 0.1 2.25 ± 0.2 2.30 ± 0.1* 2.31 ± 0.1* 2.25 ± 0.1 
Female AGD (mm) 1.65 ± 0.1 1.87 ± 0.2* 2.02 ± 0.1** 1.91 ± 0.3** 1.92 ± 0.1** 
Female AGD/cuberoot bw 1.04 ± 0.1  1.23 ± 0.2 1.43 ± 0.2** 1.28 ± 0.2* 1.29 ± 0.1** 
Data represent group means based on litter means±SD. 
PN = postnatal. Res = resorption i.e. regression of the fetus; 
 * or ** statistically significant compared to control (p<0.05 or p<0.01, respectively). Significant values are indicated in 
bold. 
¤ Because of problems with parturition caesarian section (CS)(GD23-25) was performed on 2 dams in the 100 mg/kg 
tebuconazole group and 4 dams in the 50 mg/kg epoxiconazole group. These data were included in the analysis of GD21 
CS data. 
 # AGDs were only measured in the 2nd set of animals. 
Values written in Italic are from only one dam/litter why no SD are shown. 
 
3.2.2.3 Hormone analysis 
In fetuses tebuconazole caused a statistically significant increase in testicular 
17α-hydroxy-progesterone and progesterone levels, and a decrease in 
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testosterone levels. Epoxiconazole had no significant effect on the measured 
hormone levels in fetuses (Table 10). 
 
Table 10 - Testicular hormone concentrations in male fetuses at GD21. 
  
17α-hydroxyprogesterone 
(pg/testis) 
Testosterone  
(ng/testis) 
Progesterone  
(ng/testis) 
Testosterone 
production 
(ng/testis) 
Progesterone 
production 
(ng/testis) 
Control 1.95±0.54(4) 1.75±0.71(5) 0.037±0.025(5) 3.95±1.71(6) 0.02±0.01(6) 
Tebuconazole 50 
mg/kg 8.39±2.59*7) 1.25±0.40(7) 0.103±0.035* (7) 4.77±3.49(6) 0.29±0.62(6) 
Tebuconazole 100 
mg/kg 6.59±3.88* (9) 0.88±0.46* (9) 0.084±0.063(9) 3.34±2.59(5) 0.04±0.03(5) 
Epoxiconazole 15 
mg/kg 1.76±1.36(6) 1.62±0.59(8) 0.029±0.019(8) 4.41±3.27(6) 0.00±0.00(6) 
Epoxiconazole 50 
mg/kg 0.94±0.48(13) 1.11±0.56(20) 0.027±0.019(20) 4.00±3.27(10) 0.00±0.01(10) 
Fetal testes were extracted with diethylether before measurement of progesterone, 17α-progesterone and testosterone. 
Other fetal testes were incubated in a water bath at 37°C for 3 hrs before measurement of testosterone and progesterone in 
supernatants. Data represent the mean±SD; ( ) = n; * statistically significantly different compared to control (P<0.05). 
 
In plasma from mothers obtained at GD 21, the highest dose of tebuconazole 
led to a marked increase in the progesterone level (7-fold increase), and a 
significant decrease in T3. Epoxiconazole led to an increase in the 
progesterone (7-fold increase) and surprisingly also to a pronounced increase 
in the testosterone level (2-fold), at the highest dose (Table 11). The 
increased progesterone levels in the mothers could be the explanation for the 
increased gestational length (Table 9). 
 
Table 11 - Maternal plasma concentrations of hormones and lipids at GD 21. 
  
Cholesterol 
Mean (mM) 
Triglyceride 
Mean (mM) 
T3 
Mean (nM) 
T4 
Mean (nM) 
Testosterone 
Mean (nM) 
Progesterone 
Mean (nM) 
Control 1.85±0.28(6) 7.44±2.26(6) 2.38±0.48(7) 53.53±17.45(7) 0.40±0.25(6) 48±32(6) 
Tebuconazole 50 
mg/kg 1.68±0.22(7) 4.01±0.94(7) 2.36±0.24(7) 53.14±11.95(7) 0.22±0.09(7) 113±114(7) 
Tebuconazole 100 
mg/kg 2.20±0.30(8) 6.23±1.71(8)  1.99±0.23* (8) 38.26±10.74(8) 0.32±0.17(8) 354±163*(8) 
Epoxiconazole 15 
mg/kg 1.90±0.31(8) 6.14±3.92(8) 2.47±0.25(8) 46.44±9.05(8) 0.49±0.31(9) 170±141(9) 
Epoxiconazole 50 
mg/kg 2.31±0.74(14) 12.07±7.45(14) 2.29±0.23(14) 44.09±13.92(14) 0.82±0.43* (15) 349±190* 14) 
Data represent the mean±SD; ( ) = n; * statistically significantly different compared to 
control (P<0.05). 
 
3.2.2.4 Gene expression levels 
 
Table 12 - Overview of gene expression in testis from male fetuses (GD 21). 
 
Control
 Tebuconazole
50 mg/kg 
 Tebuconazole 
100 mg/kg 
Epoxiconazole 
15 mg/kg 
 Epoxiconazole
50 mg/kg 
ScarB1 mRNA ↔ ↔ ↔ ↔ ↔ 
P450scc mRNA ↔ ↔ ↔ ↔ ↔ 
P450c17 mRNA ↔ ↔ ↔ ↔ ↔ 
StAR mRNA ↔ ↔ ↔ ↔ ↑ 
The selected genes are all involved in steroidogenesis according to Figure 3. The 
level of gene expression. 
relative to the housekeeping gene 18S. 
↔ = no effect. ↑ = up regulated 
 
Regarding expression levels of genes involved in testicular testosterone 
production no effects were observed except for an induced expression of the 
StAR mRNA in fetal testis for the highest dose of epoxiconazole (P<0.026). 
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3.2.2.5 Endpoints related to PND 1, PND 13 and PND 16 Pups 
As seen from Table 9, the highest doses of tebuconazole and epoxiconazole 
led to an increased length of gestation, increased loss of fetuses and a marked 
increase in postnatal death of the pups. In addition, the highest dose of 
epoxiconazole induced a high frequency of stillbirth leading to marked 
reduction in live litter size. The high doses of both chemicals induced slightly 
decreased body weight gain in the dams during pregnancy, but the effect was 
only statistically significant for the high dose of tebuconazole. 
 
3.2.2.6 Anogenital distance and nipple retention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 - Effect on anogenital distance at birth and nipple retention PND 13, caused 
by perinatal exposure to epoxiconazole or tebuconazole. AGD is shown as distance per 
cuberoot of body weight. T-50 and T-100 = tebuconazole (50 and 100 mg/kg bw/day). E-15 
and E-50 = epoxiconazole (15 and 50 mg/kg bw/day). The data represent the mean±SD. * 
statistically significant compared to control. # Only one pup. 
 
Both tebuconazole and epoxiconazole increased the anogenital distance in 
female offspring at birth. This was statistically significant for the highest dose 
of tebuconazole and the lowest dose of epoxiconazole (Figure 12 and Table 
9). In the male offspring the anogenital distance is significantly increased in 
the lowest epoxiconazole dose group before adjusting for body weight (Table 
9), but when AGD is divided by the cubic-root of the body weight as 
represented in Figure 12 there is no increase. In the fetuses (GD21) 
tebuconazole and epoxiconazole increased the body weight-adjusted 
anogenital distance in both males and females (Table 9). Furthermore, both 
doses of tebuconazole resulted in an increased number of nipples in male 
pups at PND 13, a tendency that was also seen for epoxiconazole 15 mg/kg 
bw/day, but was not significant (Figure 12 and Table 9). 
 
3.2.2.7 Hormone analysis 
As an increased AGD was seen in the female pups at birth (Figure 12), it was 
of interest to analyze estradiol in ovaries and testosterone in male plasma. A 
clear tendency towards lowered estradiol levels in female pups PND 16 was 
seen for both compounds. Also the plasma testosterone in male pups at the 
highest dose of tebuconazole and both doses of epoxiconazole seem to be 
lowered, however, the effects were not statistically significant (Table 13).  
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Table 13 - Hormone concentrations in ovaries (females) and testis (male) from pups PND 16. 
  
 
 
 
 
 
 
 
 
 
3.2.2.8 Gene expression levels 
No significant effects were seen on expression levels of genes in the prostate 
or epididymis in male pups PND 16 (Table 14). 
 
Table 14 - Changes in mRNA expression levels in prostate and epididymis PND 16. All 
data are from prostates except for PEM mRNA which is from epididymis. 
 
Control 
 Tebuconazole
50 mg/kg 
 Tebuconazole 
100 mg/kg 
Epoxiconazole 
15 mg/kg 
 Epoxiconazole 
50 mg/kg 
AR ↔ ↔ ↔ ↔ ↔ 
ODC ↔ ↔ ↔ ↔ ↔ 
Compl.C3 ↔ ↔ ↔ ↔ ↔ 
IGF-1 ↔ ↔ ↔ ↔ ↔ 
PBPC3 ↔ ↔ ↔ ↔ ↔ 
TRPM-2 ↔ ↔ ↔ ↔ ↔ 
PEM  ↔ ↔ ↔ ↔ ↔ 
The level of gene expression relative to the housekeeping gene 18S rRNA. 
↔ = no effect. 
 
3.2.2.9 Autopsy, Organ weight and Histopathology 
No histopathological effects on the male genital tubercle were observed. Body 
and organ weights of male and female rat offspring at PND 16 are shown in 
Table 15.A statistically significant increased liver weight is observed at a dose 
of 100 mg/kg bw/day tebuconazole. For epoxiconazole at 50 mg/kg bw/day a 
tendency towards an increase in liver weight was seen as well. No effect on the 
reproductive organ weights was observed for tebuconazole. Epoxiconazole 
was associated with increased weights of ventral prostate. The data is however 
based on only 2 organs, and no conclusions can therefore be drawn. 
 
Female reproductive organs were unaffected, and in the haematoxylin and 
eosin stain, no histopathological effects were observed in any of the examined 
male organs (testes and prostates). 
Females 
Estradiol in ovaries 
Mean( pg/ovary) 
Males 
Testosterone in plasma 
Mean (ng/ml plasma) 
Control 8.40±3.90(13) 0.14±0.18(12) 
Tebuconazole 50 mg/kg 8.40±7.00(12) 0.17±0.18(12) 
Tebuconazole 100 mg/kg 5.60±4.60(7) 0.11±0.09(7) 
Epoxiconazole 15 mg/kg 5.00±2.70(9) 0.07±0.14(7) 
Epoxiconazole 50 mg/kg 3.6 (1) 0.02 (1) 
Data represent the mean±SD. ( ) = n. Values written in italic are from one animal only. 
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Table 15 - Effects of epoxiconazole (E) and tebuconazole (T) on male and female pups PND 16. 
Male Control 
 Tebuconazole 
50 mg/kg 
 Tebuconazole  
100 mg/kg 
Epoxiconazole 
15 mg/kg 
 Epoxiconazole 
50 mg/kg 
Body weights (g) § 28.9±0.4(42) 26.6±0.7(46) 27.9±1.1(25) 25.4±o.8(29) 29.3±0.7(6) 
Right testis (mg) § 54.7±0.7(43) 53.0±1.7(44) 56.6±2.8(25) 50.2±1.7(29) 67.0±2.6(6) 
Left testis (mg) § 54.4±0.9(43) 52.7±1.7(44) 54.5±2.9(25) 49.8±1.9(29) 67.8±2.2(6) 
Epididymides (mg)§ 20.8±0.5(25) 20.1±0.7(23) 21.4±1.1(14) 20.0±1.2(16) 23.3±0.9(2) 
Ventral prostate (mg)§ 12.4±0.4(25) 12.5±0.8(21) 13.2±1.1(14) 12.4±0.9(16) 21.2±1.6*
a
 
Seminal vesicles (mg)§ 8.7±0.5(25) 8.3±0.5(23) 9.4±0.9(13) 7.2±0.4(16) 9.4±1.8(2) 
LABC   (mg)§ 26.0±0.1(12) 22.3±1.4(10) 25.3±1.8(7) 24.1±0.6(7) 30.6 
Bulbourethral gl. (mg) 1.6±0.1(11) 1.5±0.1(11) 1.7±0.2(7) 1.7±0.1(8) 2.7 
Thyroid (mg)§ 3.6±0.2(31) 3.8±0.2(33) 3.6±0.2(18) 3.3±0.2(24) 3.0±0.3(3) 
Adrenals (mg) § 8.5±0.3(26) 7.9±0.5(24) 8.7±0.9(14) 7.2±0.4(16) 6.1±3.3(2) 
Kidneys (mg)§ 295.5±7.9(13) 272.2±18.4(12) 295.3±27.5(7) 259.8±18.9(8) 333.4 
Liver (mg)§ 735.6±17.8(25) 702.3±40.6(24) 795.2±49.9*(14) 602.8±39.8(16) 801.7±58.6(2) 
Female     
Body weights (g) 29.0±0.7(24) 26.5±1.2(21) 28.2±1.9(15) 27.3±1.6(15) 27.3±0.3(2) 
Thyroid (mg)  3.9±0.6(12) 4.4±0.3(11) 3.9±0.5(6) 3.4±0.4(8) 2.6 
Uterus (mg)§ 18.7±0.6(13) 19.1±1.3(12) 19.7±1.5(6) 18.3±1.2(9) 16.6 
Ovaries (mg)  5.5±0.3(9) 5.1±0.3(7) 5.7±0.4(5) 4.7±0.3(7) 7.0 
Data represent least squares means±SEM. ( ) = n;  
* Statistical significant different compared to controls (p<0.05). § Statistically significant effect of the covariate, 
body weight (p<0.05). 
a only two organs were included in this analysis.  Values written in italic are from only one organ why no SEM is 
shown. 
 
3.2.2.10 Semen quality analysis PND 224 
Semen quality was analyzed only in the low dose groups due to maternal or 
fetotoxic effects in the high dose groups. The semen quality analysis showed 
that three samples out of twelve animals from the group exposed to the low 
dose of epoxiconazole did not contain any sperm cells, while all other samples 
contained 200-400 sperm cells (11 controls, 11 tebuconazole, 9 
epoxiconazole). The difference is statistically significant (p=3.7%) when 
compared to the combined results from the control group and the 
tebuconazole group, but not when compared to the control group alone. 
 
The results of the semen quality analysis for animals with sperm cells are 
shown in Table 16. Statistical analysis of the sperm motility including or 
excluding the three animals without sperm cells did not show any significant 
differences. 
 
Table 16 - Semen quality analysis – motility. 
Semen quality Control 
Tebuconazole
50 mg/kg 
Epoxiconazo
le 
15 mg/kg# 
Number of animals 11 11 9 
Sperm cells used for the analysis 292±18 263±14 271±18 
Motile cells, count 143±19 153±14 143±15 
Percent motile 48.6±5.9 57.6±3.7 53.0±4.1 
Progressive cells, count 73±12 80±9 70±9 
Percent progressive 24.9±3.5 30.4±3.1 26.1±3.1 
Data represent means±SEM. T-50 = tebuconazole 50 mg/kg bw/day. 
 # Without three animals not having any sperm cells. 
 
No effects were seen on curvilinear velocity (VCL), amplitude of lateral head 
displacement (ALH), or progression parameters such as average path velocity 
(VAP), straight-line velocity (VSL) or straightness (STR) (data not shown). 
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3.3 Overview of results 
Table 17 shows an overview of the qualitative results obtained from this 
study. Some of the results for prochloraz are from previous studies. 
 
Table 17 - An overview of the most important observations for the azole fungicides in 
the in vitro and in vivo test systems. 
 
  Epoxiconazole Prochloraz Propiconazole Tebuconazole
In Vitro assays 
Estrogenic activity + - + - 
Anti-estrogenic effect + + + + 
Anti-androgenic effect + + + + 
Aromatase inhibition + + + + 
AhR activity + +++ + + 
Testosterone 
production ↓ ↓ ↓ ↓ 
Progesterone 
production ↑ ↑ ↑ ↑ 
E2 production ↓ ↓ ↓ ↓ 
Thyroid effect - - - antagonism 
In Vivo experiments 
Hershberger Study Not investigated +++ 
↑ liver weights 
↑ FSH level 
↓ ODC mRNA 
↑ liver weights
↓ ODC mRNA
Developmental Toxicity 
  Not 
investigated 
 
Gestational length ↑ ↑ - ↑ 
Fetal toxicity 50 mg/kg > 100 mg/kg - 10 mg/kg 
AGD/ cuberoot bw in 
males 
 ↓ -  
AGD/cuberoot bw in 
females ↑ ↑ 
- ↑ 
Nipples (male PND 13) - ↑ - ↑ 
Hormone analysis in 
fetal testis 
- ↑ Progesterone ↓ Testosterone 
- ↑ 
Progesterone
↓ 
Testosterone 
Hormone levels in 
mothers 
↑ Testosterone
↑ 
Progesterone 
 
- ↑ 
Progesterone
↓ T3 
Gene expression (PND 
16 prostate) 
- ↓ ODC, PBP C3 and 
IGF-1 mRNA 
- 
- 
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4     Discussion  
 
Several pesticides have been demonstrated to be ER agonists or AR 
antagonists in various in vitro test systems (Andersen et al., 2002; Kojima et 
al., 2004). However, the affinities for the steroid receptors are very low 
relative to endogenous hormones and therefore it could be questioned 
whether these mechanisms alone can induce effects in vivo at environmentally 
relevant concentrations. However, it is conceivable that chemicals with the 
ability to act via several endocrine pathways are more likely to cause effects in 
vivo due to the combined response from different mechanisms (Sanderson, 
2006; Sharpe, 2006). Furthermore, as humans are rarely, if ever, exposed to 
one single chemical at a time, the combined exposure to several chemicals 
acting via the same pathway may cause adverse effects in humans. 
 
The results from the in vitro investigations in this study demonstrate that the 
three azole fungicides: propiconazole, tebuconazole, and epoxiconazole all 
had the ability, like prochloraz, to act via several different mechanisms. The 
three triazoles were less potent than prochloraz to act as ER antagonists 
(prochloraz > tebuconazole ≈ epoxiconazole ≈ propiconazole) and AhR 
agonists (prochloraz >>> tebuconazole ≈ epoxiconazole ≈ propiconazole) 
while the potency as AR antagonists was similar. Like prochloraz, the triazoles 
were aromatase inhibitors, although again, with lower potency than prochloraz 
(prochloraz >epoxiconazole ≈ tebuconazole > propiconazole). 
 
While several pesticides have been reported to be ER agonists in vitro only 
prochloraz (Andersen et al., 2002) and some pyrethroid insecticides (Kim et 
al., 2004) have, to our knowledge, been reported to be ER antagonists. The 
impact of this mechanism for the integrated response in vivo is unknown at 
present and no standardized method for investigating this effect in vivo have 
been established.  The results obtained in this study on aromatase (CYP19) 
inhibition is in accordance with previous studies (Trosken et al., 
2004;Trosken et al., 2006;Vinggaard et al., 2000)  in which prochloraz was 
also identified as a stronger aromatase inhibitor than the other fungicides 
tested. 
 
The higher potency of prochloraz towards the ER, and especially the AhR, 
indicates that the molecular structure of this compound favour the ability to 
bind to these receptors. In general, high-affinity AhR ligands are planar 
aromatic polycyclic molecules such as the prototypical ligand 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) (Rifkind, 2006). The number and 
places of halogens affect the planarity of the molecule and computer 
modelling could be used for comparison of the conformation of the different 
azole molecules but such analysis have not been performed. Since the 
affinities of the triazoles for the ER and AhR were similar in spite of their 
varied number and placement of halogens, it seems more likely that the 
differences in affinities between prochloraz and the triazoles are related to the 
imidazole structure. 
 
The results from the H295R steroid hormone synthesis assay showed that the 
triazoles, as well as prochloraz, inhibited testosterone and estradiol 
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production, and increased progesterone production. This indicates that 
enzymes involved in the conversion of progesterone to testosterone are 
inhibited. Azole fungicides and azole antifungal drugs are designed to inhibit 
the biosynthesis of ergosterol in fungi by inhibiting the cytochrome P450 
enzyme 14α-lanosterol demethylase (CYP51). In fungi the lack of ergosterol 
leads to collapse of the cell membrane. In humans CYP51 is important for the 
conversion of lanosterol to cholesterol and in the production of meiosis 
activating steroids. Thus, inhibition of human CYP51 may disturb steroid 
synthesis. Prochloraz, propiconazol, tebuconazol, and epoxiconazol have all 
been reported to inhibit human CYP51 (Trosken et al., 2006) but with lower 
potency than the antifungal drugs miconazole and ketoconazole. The azole 
compounds are not selective for CYP51 and a range of other cytochrome 
P450 enzymes, including aromatase and other CYP enzymes involved in 
steroidgenesis, are also affected by azole compounds. Hence, CYP17 (17α-
hydroxylase and/or 17,20-lyase activity), which are involved in the conversion 
of cholesterol to testosterone (see Figure 3), has been demonstrated to be 
inhibited by several azole compounds including the imidazole fungicides 
imazalil and prochloraz as well as and some imidazole antifungal drugs (e.g., 
ketoconazol) (Ayub and Levell, 1987;Ayub and Levell, 1989;Mason et al., 
1987). Hence, the reduced testosterone and estradiol synthesis and increased 
progesterone production observed for all four azole fungicides in the H295R 
steroid synthesis assay might, at least partly, be due to inhibition of CYP17. 
 
Several other cytochrom P450 enzymes have also been reported to be affected 
by azole compounds. Enzymes of the CYP1, CYP2 and CYP3 gene families 
were induced by some azoles (Juberg et al., 2006;Mason et al., 
1987;Sanderson et al., 2002;Sun et al., 2005) and inhibited by others (Zhang 
et al., 2002).The triazole fungicide, fenbucazole, was recently reported to be a 
phenobarbital-type inducer of mouse liver cytochrom P450 and to cause a 
dose-dependent increase in liver weight associated with hepatocellular 
hypertrophy and vacuolation (Juberg et al., 2006). In a recent study in adult 
male rats, the four triazole fungicides: fluconazole, myclobutanil, 
propiconazole, and triadimefon all affected the expression of several CYP 
genes in liver and testis including genes involved in steroid metabolism (Tully 
et al., 2006). The induction of CYP1 enzymes is mediated by the Ah receptor. 
The Ah receptor is a transcription factor that after binding of ligand causes 
increased gene transcription of Ah receptor responsive genes such as the 
CYP1 gene family. CYP1A1 and 1A2 metabolize estradiol to 2- and 4-
hydroxy estradiol (Rifkind, 2006) and induction of these enzymes could 
therefore affect the hormone concentration in the organism. All four azole 
compounds in this study acted as AhR agonist and hence, they might induce 
the activity of CYP1 enzymes. Prochloraz was by far the most potent of the 
four azoles. 
 
No significant and convincing effect on thyroid-receptor mediated 
proliferation was found for any of the azole fungicides. However, in a similar 
assay prochloraz  inhibited the T3-induced growth of GH3 cells in a 
concentration dependent way to 55 % of the reference level (Ghisari and 
Bonefeld-Jorgensen, 2005) and in animals both prochloraz and tebuconazole 
have shown effects on thyroid function (Pesticidkontoret, 1996b;Vinggaard et 
al., 2002). However, this effect could be due to other mechanisms than direct 
interaction with the TR. 
 
The anti-androgenic effects observed in the AR assay in vitro were not 
confirmed in vivo when tebuconazole and propiconazole were tested in the 
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short-term Hershberger assay. In contrast to prochloraz that induced marked 
anti-androgenic effects at doses between 50 and 150 mg/kg bw/day, no anti-
androgenic effects were observed for tebuconazole or epoxiconazole at doses 
below150 mg/kg bw/day. At 150 mg/kg bw/day, FSH levels were increased by 
propiconazole, and at this dose level both compounds caused a down-
regulation of ODC mRNA in ventral prostates. ODC is an androgen-
regulated gene but is regulated by other pathways as well including regulation 
by estrogens (Nellemann et al., 2005). Since none of the other end points 
(weight of androgen dependent organs, expression of androgen responsive 
genes or serum concentration of LH) were affected we believe that the effects 
observed on ODC mRNA expression are due to a non-androgen-regulated 
pathway. The design of the Hershberger assay is optimised to detect effects 
on organ weights and not for detecting changes in gene expression and our 
previous experience supports that changes in weights of reproductive organs 
is a more sensitive parameter for anti-androgenicity in this animal model than 
gene expression in prostates. Liver weights were increased with the highest 
doses of both tebuconazol and propiconazole. A stimulation of liver growth is 
often observed with chemicals that induce microsomal liver enzymes 
including the cytochrom P450 enzyme system (Juberg et al., 2006) and this 
has been observed previously for prochloraz. 
 
No other studies on anti-androgenic effects of azole fungicides in adult 
animals were found, but among the pharmaceuticals, the imidazole 
ketoconazole exhibited anti-androgenic effects in rats by reducing serum 
androgen level and increasing estradiol, FSH and LH levels. The weights of 
androgen sensitive organs (epididymides, prostate, and seminal vesicles) were 
reduced (Marty et al., 2001;O'Connor et al., 2002). Ketoconazole also 
reduced testosterone synthesis in male human volunteers after a single oral 
dose of 400 mg and ketoconazole as well as other imidazole antifungal drugs 
(isoconazole, miconazole, econazole, and clotrimazole) inhibited 
testosterone production in mouse Leydig cells in vitro (Schurmeyer and 
Nieschlag, 1984). The triazole compound fluconazole did not reduce 
testosterone levels in men after oral doses of 25 or 50 mg/kg lgv/day for 28 
days (Hanger et al., 1988). 
 
Examination of reproductive development in offspring after exposure during 
pregnancy and lactation is presently considered to be the most sensitive 
animal model system to detect endocrine disrupting effects. In mammals sex 
determination and sexual differentiation are under strictly hormonal control 
and even minor disturbances in steroid hormone concentration or function 
during critical periods of development may affect the process (Sharpe, 2006). 
In this study, effects on reproductive development in offspring (fetuses and 
pups) were investigated for two of the triazoles: tebuconazole and 
epoxiconazole. Epoxiconazole was not included in the original study plan, but 
during 2005 we were informed that the use of epoxiconazole had increased 
dramatically and now was one of the most widely used azole fungicides in 
Denmark. In light of the negative results for propiconazole in the Hershberger 
test and of the more limited use of this pesticide in Denmark, we decided to 
include epoxiconazole instead of propiconazole. 
 
Previous studies have demonstrated that perinatal exposure to prochloraz 
feminized male offspring and virilized female offspring (Laier et al., 2006; 
Noriega et al., 2005; Vinggaard et al., 2005a). The results from this study, 
demonstrate that also tebuconazole cause feminization of male offspring as  
both doses (50 and 100 mg/kg bw/day) caused increased number of nipples 
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and at the highest dose, the testosterone concentration in fetal testis was 
reduced. The AGD was unaffected at birth but in male fetuses (GD21) an 
increased AGD, an indicator of masculinization, was observed for the highest 
dose of tebuconazole. However, this effect on AGD had disappeared after 
birth and since the other end-points mentioned indicate feminization, our 
conclusion is that the dominating effect of tebuconazole in male offspring is a 
feminization. In female fetuses, both doses of tebuconazole caused increased 
AGD and, for the highest dose, this effect was also evident at birth. The 
virilizing effect in female offspring is also supported by a decreased estradiol 
concentration in the ovaries at PND16, although this effect was not 
statistically significant. The feminizing effect of males and virilizing effect of 
females are in agreement with another study demonstrating reduced weight of 
epididymis in adult male offspring and reduced uterus weight in adult female 
offspring after perinatal tebuconazole exposure (Moser et al., 2001) although 
the weight of epididymis and uterus was not affected in the offspring at 
PND16 in our study. 
 
The testicular progesterone level in male fetuses was elevated after 
tebuconazole exposure and this, together with the lowered testosterone level, 
indicates a direct impact on the steroid synthesis pathway in the Leydig cells. 
This is also supported by the in vitro results on steroid hormone synthesis 
obtained for tebuconazole. The effects observed on hormone concentrations 
and nipple retention for tebuconazole are comparable to our previous results 
for prochloraz (Vinggaard et al., 2005a). The changes in hormone level may 
(as mentioned earlier) be an indication of CYP 17 inhibition. 
 
Epoxiconazole acts differently in vivo than the other tested azoles, as a marked 
fetotoxic effect was observed. The dams dosed with 50 mg/kg were in general 
unable to deliver their pups. Only two litters were born normally while the 
other litters were included in the caesarian sections at GD21. Thus, the data 
for this dose of epoxiconazole on the live born pups is based on a very limited 
number of animals. Like tebuconazole, epoxiconazole seemed to increase 
AGD in male fetuses but the effect is not persistent at birth. No feminizing 
effects on male fetuses were seen. In contrast an increased birth weight was 
seen with epoxiconazole which may be related to the marked up-regulated 
levels of testosterone in the dams. We suggest that the increased androgen 
exposure during pregnancy may have had a growth promoting effect on the 
pups. Overall, epoxiconazole seems to alter sex hormone levels in the dams, 
but not in the fetuses.  In female offspring, AGD was increased in fetuses as 
well as in pups at birth indicating a virilizing effect. As for tebuconazole, the 
virilizing effect of epoxiconazole is supported by a lower (non-significantly) 
estradiol concentration in the ovaries at PND16. 
 
Our findings on epoxiconazole are in accordance with the studies reported 
when epoxiconazole was approved for use in Denmark (Pesticidkontoret, 
2003). In these studies, the fertility of male rats was reduced, gestational 
length was increased, the number of live born rat pups was reduced, and the 
weight of the adrenal glands in male offspring was reduced in a 2-generation 
study in rats using doses between 30 ppm (approx. 3 mg/kg bw/day) and 
1500 ppm (approx. 125 mg/kg bw/day) in the feed. To our knowledge, no 
other studies on reproductive or endocrine disrupting effects of epoxiconazole 
have been published. 
 
Hence, both triazoles caused virilization of the female offspring after perinatal 
exposure and these effects resemble those previously observed for prochloraz 
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(Laier et al., 2006). Male offspring was feminized by tebuconazole but not by 
epoxiconazole. Epoxiconazole was a clear reproductive toxicant and this effect 
may overshadow any possible endocrine disrupting effect in male pups.The 
effects induced by tebuconazole were comparable to effects induced by 
prochloraz (her så vi effekter ved 30 mg/kg) although prochloraz had a higher 
potency compared to tebuconazole. 
 
Both tebuconazole and epoxiconazole induced a high plasma concentration of 
progesterone in the mothers. This is probably the reason for the increased 
gestational length as also previously seen for prochloraz (Vinggaard et al., 
2005a). In utero exposure to natural or synthetic progesterons can induce 
hypospadia in male mice and the synthetic progesterone 
medroxyprogesterone acetate feminize male and virilizes female genitala 
(Willingham et al., 2006). Thus, the high maternal progesterone 
concentration is likely to be involved in the virilizing effect of the female 
offspring. Whether any potential aromatase inhibition and/or ER antagonism 
in vivo are also involved cannot be ruled out from these data. The limited 
hormone analyses performed on the female pups indicate a tendency towards 
reduced estradiol concentration in the ovary, while effects on fetal 
progesterone levels were not investigated. For epoxiconazole, the maternal 
testosterone concentration in plasma was markedly increased and this may 
also have contributed to the effects observed in the offspring. Besides, it 
indicates a virilizing effect in the mothers. Since epoxiconazole was not 
included in the Hershberger assay, we have no hormone measurements from 
adult male rats but in studies reported as a part of the approval 
(Pesticidkontoret, 2003) increased serum concentrations of testosterone, 
androstendion, FSH, and ACTH as well as reduced estradiol, corticosterone, 
and aldosterone was reported in adult male rats.  In females increased serum 
concentrations of dihydroepiandrosterone, androstendion, LH, FSH, and 
ACTH as well as reduced estradiol, prolactin, corticosterone, and aldosterone 
was reported after oral administration of approximately 250 mg/kg bw/day 
(3000 ppm in the feed) for 28 days. 
 
The endocrine disrupting properties demonstrated for many pesticides in vitro 
have only been confirmed in vivo for a limited number of pesticides. These 
include some of the ‘old’ persistent organochlorine insecticides such as DDT 
and methoxychlor (Shelby et al., 1996), and some fungicides: procymidon 
(Gray, Jr. et al., 1999b;Lambright et al., 2000;Ostby et al., 1999), vinclozolin 
(Gray, Jr. et al., 1999a;Kelce et al., 1994), fenarimol (Andersen et al., 
2006;Vinggaard et al., 2005b), and prochloraz (Vinggaard et al., 
2002;Vinggaard et al., 2005a). General traits for these pesticides are their 
ability to react with more than one steroid hormone receptor (Andersen et al., 
2002;Gaido et al., 2000;Molina-Molina et al., 2006;Radice et al., 2006;Sohoni 
and Sumpter, 1998) and to affect the expression of enzymes involved in 
steroid synthesis and/or metabolism (Delescluse et al., 1998;Sanderson, 
2006;Vinggaard et al., 2006;Zachow and Uzumcu, 2006). Whether the ability 
to act via different mechanisms is a major contributing factor in inducing 
endocrine disrupting effects in vivo, is not known at this time. The importance 
of the different mechanisms for the integrated in vivo response may differ 
between compounds and may also depend on the developmental stage of the 
exposed organism. 
 
We have previously demonstrated that another fungicide, fenarimol, had 
estrogenic properties in vitro in the MCF-7 cell proliferation assay as well as in 
vivo where the compound increased uterine weight in ovariectomized female 
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rats (Andersen et al., 2006). In addition, fenarimol is an anti-androgen in vitro 
(Vinggaard et al., 1999) and causes anti-androgenic effects in the Hersberger 
assay in vivo (Vinggaard et al., 2005b). Fenarimol inhibits aromatase activity 
(Sanderson et al., 2002; Vinggaard et al., 2000) and affects a range of other 
cytochrom P450 enzymes including key enzymes involved in steroid hormone 
biosynthesis (Paolini et al., 1996). Like the azole fungicides, fenarimol was 
reported to increase progesterone concentration in pregnant rats leading to 
delayed parturition (WHO, 1995). In some older studies, a reduced fertility of 
male rats was observed and suggested to be related to an effect in the central 
nervous system controlling sexual behavior (Hirsch et al., 1987) but the exact 
mechanism were not explored. No studies on reproductive development in 
offspring after exposure of pregnant animals to fenarimol have been reported. 
 
The dicarboximide fungicide vinclozolin was one of the first pesticides 
identified as a potent in vitro and in vivo androgen antagonist and to disturb 
sexual development in male pups after perinatal exposure exhibiting reduced 
AGD, nipple retention and hypospadia (Colbert et al., 2005; Gray, Jr. et al., 
1994; Gray, Jr. et al., 1999a; Kelce et al., 1994; Nellemann et al., 2003). 
Recently, vinclozolin was also reported to virilize female fetuses in mice after 
prenatal exposure and to up-regulate progesterone receptor mRNA in 
offspring of both sexes while ER mRNA was down-regulated in females and 
up-regulated in males (Buckley et al., 2006).  Vinclozolin has also been 
reported to affect the activity of a range of cytochrom P450 enzymes in mice 
by increasing the activity of some and inhibiting others depending on dose, 
sex and organ (Hrelia et al., 1996). In addition, vinclozolin was reported to 
increase the activity of aromatase and mRNA expression in H295R human 
adrenocortical cells identified (Sanderson et al., 2002). A recent study 
demonstrated that vinclozolin and its two major metabolites were not only AR 
antagonists, but also ER agonists and that vinclozolin and one of the 
metabolites (M2) were progesterone and mineralocorticoid receptor 
antagonists and M2 was also a glucocorticoid receptor antagonist (Molina-
Molina et al., 2006). Hence, also vinclozolin possess the ability to induce 
endocrine disruption via a range of different mechanisms. Recently, 
vinclozolin was shown to alter the spermatogenic capacity of male germ cells 
and sperm viability via its effects on DNA methylation and fetal exposure to 
vinclozolin during gonadal sex determination in rats caused reduced fertility 
and sperm development in the adult testis (Uzumcu et al., 2004). Alarmingly, 
this phenotype was transmitted through the male germ line to at least 
generation F4 without any further exposure (Anway et al., 2005). Testis from 
the F2 generation at PND20 had normal morphology but an increase in 
spermatogenic cell apoptosis. At PND60 (adult) the morphology was still 
predominantly normal but the germ cell apoptosis was significantly increased 
(Anway et al., 2006). A similar transgenerational transmission of endocrine 
disruption was also demonstrated for methoxychlor (another well known 
endocrine disrupting pesticide) in the same study (Anway et al., 2005) 
indicating that this phenomenon also might apply to other endocrine 
disrupters. 
 
In conclusion, all three triazole fungicides included in this study possessed 
similar properties as prochloraz to act via several endocrine disrupting 
pathways in vitro although the potency in some of the assays were lower than 
for prochloraz. However, the potency of the triazole fungicides in vivo might 
be higher than predicted from the in vitro studies since both tebuconazole and 
epoxiconazole were capable of inducing effects on reproductive development 
in the offspring after exposure in utero. These effects are likely due to several 
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different mechanisms operating simultaneously and thereby enhancing the 
integrated biological response. The lack of effect in the Hershberger assay 
(where effects on steroid synthesis is omitted by using testosterone 
supplemented castrated male rats) combined with the effects on reproductive 
developmental after perinatal exposure strongly indicate that one of the main 
responsible mechanisms is disturbance of key-enzymes involved in synthesis 
of steroid hormones. Subtle effects on hormone levels might be without 
clinical effects in adults because of a tightly controlled homeostasis but could 
have detrimental effects if they occur under vulnerable stages of reproductive 
development in the fetus (Sharpe, 2006; Toppari et al., 2006). 
 
Although the endocrine disrupting potency for the individual triazole 
compounds seems rather low compared to the concentrations of these 
compounds in the environment and diet, exposure to several azole fungicides 
(both triazoles and imidazoles) simultaneously is likely due to the wide use of 
these compounds. Since, the azole fungicides share several mechanisms (e.g., 
ER and AR antagonism, Ah receptor agonism, and effects on steroid hormone 
synthesis including inhibition of aromatase) the combined effects induced by 
these fungicides might be additive. Likewise, they can also add to effects 
induced by other environmental endocrine disruptors sharing similar 
mechanisms (Birkhoj et al., 2004; Rajapakse et al., 2002; Silva et al., 2002). 
Thus, it is important to survey and minimize the exposure of the human 
population to azole fungicides. 
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5 Conclusion 
 
The main objective of this study was to investigate endocrine disrupting 
mechanisms and effects of three frequently used triazole fungicides: 
tebuconazole, propiconazole and epoxiconazole. The background for the 
study was our previous findings on the imidazole fungicide, prochloraz, which 
was demonstrated to possess multiple endocrine disrupting mechanisms, to be 
anti-androgenic in adult male rats, and to disturb reproductive development 
in the offspring after perinatal exposure. 
 
Overall the results from this study reveal that also other azole fungicides have 
the abilities to act as endocrine disruptors via a range of different mechanisms. 
The affinities of tebuconazole, propiconazole, and epoxiconazole for the ER 
and AhR were less than for prochloraz while the affinities for the AR were 
similar. Like prochloraz, all three triazoles caused enhanced production of 
progesterone and reduced synthesis of testosterone and estradiol in vitro in the 
human adrenocortical carcinoma cell line H295R. Neither prochloraz nor the 
three triazoles showed convincing interactions with TR. Whether the 
differences in potencies between prochloraz and the triazole fungicides in 
some of the in vitro assays are due to the triazole ring compared to the 
imidazole ring and/or related to the number and placement of halogens in the 
phenyl ring cannot be concluded from the data in this study. 
 
Unlike prochloraz, tebuconazole and propiconazole did not induce anti-
androgenic effects in vivo in adult male rats in the Hershberger assay.  
However, tebuconazole and epoxiconazole were capable of inducing effects 
on reproductive development in the offspring after perinatal exposure. Both 
compounds caused an increased gestational length and virilization of the 
female offspring evidenced by increased AGD and the effects resemble those 
previously observed for prochloraz.  Like prochloraz, male offspring was 
feminized by tebuconazole evidenced by increased retention of nipples and 
reduced testosterone concentration in fetal testis. The effect of tebuconazole 
on AGD was less than for prochloraz and at birth AGD was not statistically 
significant shorter than controls. No feminizing effect on male offspring was 
seen for epoxiconazole. It appeared to be a potent fetotoxic compound and 
dams dosed with 50 mg/kg were in general unable to deliver their pups. A 
growth promoting effect on pups was seen with the lowest dose (increased 
birth weight, increased AGD) which may be related to the marked up-
regulation of testosterone levels in the dams. 
 
Overall the profile of action in vitro of the four azole fungicides was relatively 
similar (except for the AhR response). However, the profile of action in vivo 
in the developmental toxicity studies varied. Tebuconazole possess a more 
classical endocrine disrupting effect on male pups like the one seen for 
prochloraz (increased nipple retention, reduced fetal testosterone and 
increased progesterone). However, epoxiconazole is first of all markedly 
fetotoxic and secondly it causes altered sex hormone levels in the dams but 
not in the fetuses. The common features for all three fungicides are the 
increased gestational length and the virilizing effect on female pups. The lack 
of effect from the triazoles in the Hershberger assay, the effect on steroid 
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hormone synthesis in the in vitro assay combined with the enhanced maternal 
plasma concentration of progesterone and the decreased fetal testicular 
concentration of testosterone after exposure of pregnant rats strongly indicate 
that interference with key-enzymes involved in steroid hormone synthesis is 
one of the major mechanism behind the developmental effects in the 
offspring. 
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6 Perspectives 
 
6.1 Research perspectives 
The results from this study demonstrate that the triazole fungicides, 
tebuconazole, propiconazole, and epoxiconazole, like the imidazole fungicide 
prochloraz, are able to act as endocrine disruptors during several pathways. In 
addition, the results strongly indicate that interference with steroid hormone 
synthesis is the major mechanism behind the observed effects on reproductive 
development in offspring after prenatal exposure. The results indicate that 
inhibition of CYP17 (an enzyme involved in the conversion of cholesterol to 
progesterone and testosterone) may be one of the targets but other 
steroidogenic enzymes may also be affected. This issue deserves further 
studies in order to elucidate which enzymes are affected and the relative 
impact of this for the total response in vivo. 
 
Male fetuses are considered to be more sensitive towards endocrine disruptors 
than female fetuses because development of the male phenotype requires 
more hormonal regulation than female development (Sharpe, 2006). 
However, the two triazoles tebuconazole and epoxiconazole both virilized 
female offspring while the effects on male offspring were less pronounced. 
Further studies on virilizing effects on female pups after exposure to 
endocrine disrupters are wanted to confirm these observations and to 
elucidate the mechanism behind. The impact of virilization for the female 
fertility as adults would also be interesting to investigate. 
 
Some phthalates esters (DBP, DEHP, and BBP) disrupt male reproductive 
development after in utero exposure in rats (Foster, 2006) although these 
substances do not block the AR (Mylchreest et al., 1999). The effects include 
decreased AGD, nipple retention and malformations of the external genitalia 
including hypospadias and cryptorchidism. The critical mechanism for 
induction of these effects is a marked reduction in fetal testicular testosterone 
production at the critical window for development of the reproductive tract. 
Hence, in several ways the effects observed for the azole fungicides resembles 
those seen for the phthalates. Phthalates also had other effect on Leydig cell 
function including reduced production of insulin-like factor 3 (insl3) and 
changes in gene-expression of a number of enzymes and transport proteins 
involved in normal testosterone biosynthesis and transport. It would be 
obvious to further investigate if azole fungicides have similar effects on Leydig 
cell function as the phthalates. 
 
The recent observation, that fetal exposure to vinclozolin or methoxychlor 
during gonadal development caused decreased spermatogenetic capacity, not 
only in the exposed males, but also in subsequent generations is a matter of 
concern. Hence, the ability of other endocrine disruptors, inclusive azole 
fungicides, to reprogram the germ line and to produce a trans-generational 
effect on reproductive capacity should be investigated. These studies should 
include examination of sperm production and apoptosis in spermatogenic 
cells. 
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6.2 Regulatory perspectives 
The endocrine disrupting properties of azole fungicides demonstrated in this 
study, as well as in our previous studies on prochloraz, identify azole 
fungicides as a group of endocrine disruptors capable of inducing effects via 
several different mechanisms. This makes the risk assessment more complex 
since many different end-points have to be considered but in general we 
strongly recommend that all azole fungicides are regarded and regulated as 
endocrine disruptors until the individual substances have been properly 
tested. 
 
The results from this study indicate that interference with key-enzymes 
involved in steroid hormone biosynthesis may be a central mechanism behind 
the observed effects on reproductive development. This illustrates the 
importance of applying assays for disruption of steroidogenesis when 
chemicals are screened for potential endocrine disrupting properties, since 
chemicals with weak or no affinity for the ER and/or AR may still induce 
endocrine disruption in vivo during this mechanism. 
 
Since azole fungicides are commonly used in agriculture, the population 
might be exposed from residues in food products and from drifting from 
sprayed areas. In addition, occupational exposure takes place in agriculture 
and horticulture. The azole fungicides seem to share several modes of actions 
and therefore the effects might be additive if the population are exposed to 
more azole fungicides simultaneously. This is very likely to occour via the 
diet. Hence, there is a need for better surveillance of the exposure situation of 
these fungicides. This could be obtained by including more of the azole 
compounds in the surveys of food products. Especially those used in largest 
amounts, such as epoxiconazol, should be included. In addition, development 
of biomarkers to investigate the exposure level in occupationally exposed 
groups and in samples from the general population is warranted. Until more is 
known about the potential risk of these compounds, efforts should be taken to 
minimize the exposure of especially women in the childbearing age group as 
well as children to these compounds. 
 
Prochloraz is no longer approved for sale in Denmark after 2006. However, 
the compound has not been banned for used by the authorities and therefore 
remains can be used legally and according to experience from other products 
this process may take several years. A more effective way to reduce the 
exposure of the Danish population would be a regular ban, sine this would 
minimize (ideally eliminate) occupational exposures and exposure from 
Danish produced food stuffs immediately. In addition, a ban would also give a 
signal to other countries about the potential health risk assessed for this 
pesticide. 
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